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1.1 The Post-Genomic Research 
 
The explosive growth of genetic sequence information has offered us a 
comprehensive collection of the protein sequences found in many living organisms.  
One of the great challenges of the post-genomic era is to be able to rapidly 
attribute specific biological functions to each gene sequence. The challenge of 
understanding these gene products has led to the development of functional genomics 
methods, which collectively aim to imbue the raw sequence with biological 
understanding.  
At present (October 2005), genome sequences for 68 archea, 964 bacteria,  
1007 eukaryota and 1488 viruses are available (Genome Projects Database: 
www.ncbi.nlm.nih.gov/Genomes/index.html). This wealth of information becomes 
particularly attractive because it can contribute to unraveling the basic mechanisms of 
life. However, this potential can be fully exploited only through a detailed study of 
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biomolecular structure and dynamics of the gene products, of the interactions between 
macromolecules (proteins, DNA and RNA) and of the complex regulation 
mechanisms. 
Protein structure represents a powerful mean of discovering function, because 
structure is well conserved over evolutionary time, and it therefore provides the 
opportunity to recognize homology that is undetectable by sequence comparison.  
This became apparent with the first two protein structures that were determined, 
because their common ancestry was clear from the three-dimensional fold [1], 
although their sequences did not contain recognizable similarity [2].  
Structural genomic and structural biology represent two aspects of research in 
the post-genomic era. The former is the high throughput structural characterization of 
proteins, with complete coverage relative to genomic information. This can be 
achieved through computation of three-dimensional structural models of the molecules 
with a quite high accuracy in comparison to the top level obtainable with the presently 
available technologies. The second aspect consists of the refinement and the detailed 
analysis at atomic level of the structure of biological macromolecules, with the 




1.2 NMR in Structural Biology 
 
NMR has a central role within structural biology in the post-genomic challenge 
providing structures of macromolecules at atomic resolution.  
Playing in concert with other techniques of structural analysis, mainly X-ray 
crystallography but also cryo-electron-microscopy and molecular modeling, together, 
they have unique strengths, providing a complementarity of approaches to completely 
describe the relationship between sequence and structure in molecular biology. 
With the detailed three-dimensional structure of protein in solution, NMR plays, 
consequently, a pivotal role not only in the biological field, but also in pharmaceutical 
research as a basis for a detailed understanding of molecular functions and as a 
foundation for protein design. 
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Whereas x-ray crystallography requires single crystals, high field NMR 
spectroscopy is the only existing method for structure determination of soluble 
proteins and protein domains in solution. 
Structural analysis by NMR does not require protein crystals. Most (~75%) of the 
NMR structures in the Protein Data Bank (www.rcsb.org/pdb/) do not have 
corresponding crystal structures, and many of these simply do not provide diffraction 
quality crystals. Furthermore, while most crystal structures are determined under 
physiologically relevant conditions, in many cases somewhat exotic solution 
conditions are required for crystallization. NMR studies can be carried out in aqueous 
solution under conditions quite similar to the physiological conditions under which the 
protein normally functions. This feature allows comparisons to be made between 
subtly different solution conditions that may modulate structure-function relationships. 
For example, pH titration data can be used to determine pKa values of specific 
ionizable groups in the protein and to characterize the corresponding structure-
function relationships.  
The characterization in solution can go beyond the static picture of a single 
structure, as it can provide information on the internal mobility of the protein on 
various time scales. It has already been pointed out that internal mobility can play a 
determinant role in the biological functions. 
NMR has special value in structural genomics efforts for rapidly characterizing 
the ‘foldedness’ of specific protein.  The dispersion and lineshapes of resonances 
measured in 1D 1H-NMR and 2D 15N-1H or 13C-1H correlation spectra provide 
‘foldedness’ criteria with which to define constructs and solution conditions that 
provide folded protein samples (fig. 1.1). The 2D 15N-1H correlation spectra can be 
recorded in tens of minutes with conventional NMR systems and moreover, it offer us 
the advantage of being able to monitor the interaction of the proteins with other 
biomolecules (fig. 1.2). 
With NMR spectroscopy, therefore, a complete description of the molecule can be 
obtained, ranging from the 3D detailed structure, to the folding process to the internal 















Fig. 1.1  Folded and unfolded protein: a) 2D 15N-1H HSQC spectra of Calmodulin 
(CaM) display a broad distribution of NMR frequencies resulting in a good spread-out 
of signals dispersion of folded protein, b) 2D 15N-1H  HSQC  for the unfolded alpha-
Synuclein (AS) protein share similar NMR frequencies resulting in heavy overlap of 














Fig. 1.2  Protein–protein interaction analysis by nuclear magnetic resonance 
spectroscopy:   c) Superimposed 1H-15N HSQC spectra of Human Ca2+-CaM (blue) 
and 1H-15N HSQC spectra of Human Ca2+-CaM upon complexation (red) with 
unlabelled AS recorded at 700 MHz proton frequency.  15N enriched  CaM is titrated 
with increasing amounts of AS until 1:1 molar ratio, d) part of the spectrum contains a 
some peaks that change their position during the titration. The change in the amide 
proton chemical shifts of some residues of CaM in presence of non-labeled AS 




1.3 Protein Folding and Misfolding 
 
The study of protein folding is an extraordinarily complex process, because it 
involves an extremely heterogeneous series of molecular transitions taking place in a 
solution environment often on a time-scale of seconds or less. Until recently, with the 
significant advances in theoretical, technical and experimental approaches, it is now 
possible to deal with a problem which was considered before as intractable. 
NMR spectroscopy has been central in the studies of protein folding problem 
because of its capability to define the structures of proteins in solution, to design 
proteins with new functions and to characterize the dynamic properties that are 
inherent in the folding process. NMR 3D structural determination has led to the 
characterization of several proteins containing functionally relevant disordered 
regions. Additionally, NMR has surpassed other techniques, such as crystallography, 
in characterizing proteins that lack a rigid tertiary fold, i.e. natively unfolded proteins.  
Many gene sequences in eukaryotic genomes encode entire proteins or large 
segments of proteins that lack a well-structured three-dimensional fold. 
In contrast to the traditional view that function equates with a stable three-dimensional 
structure or depends on structural alternations between different conformations, 
examples of non-structured segments of proteins, which may play important roles in 
protein function, have been discovered. The literature now contains numerous reports 
of disordered regions, highly conserved between species in both composition and 
sequence,  that are essential for function. These disordered regions include molecular 
recognition domains, protein folding inhibitors and flexible linkers. 
 For example, it is well known that locally structural disorder is necessary for 
Calmodulin binding activity. The flexibility within its interdomain linker, combined 
with the inherent deformability of the hydrophobic pockets, is thought to account for 
the ability of CaM  to interact with a variety of different targets in a sequence-
independent fashion [3,4]. 
The functional role of intrinsically disordered proteins in crucial process of  
regulatory functions in the cell, such as transcriptional regulation, translation and 
cellular signal transduction has only recently been recognized. The intrinsic lack of 
structure or partial disorder can confer functional advantages on a protein, such as 
their ability to alter their local and global structure in order to bind to several different 
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targets. In other words, flexible chains can adopt different conformations to fit to 
different ligands. Indeed, a significant advantage of intrinsic disorder is to allow one 
regulatory region or protein to bind to many different partners, including both proteins 
and nucleic acids.  
An important regulatory mechanism that has emerged in recent years involves 
the post-traslational “marking” of regulatory regions at numerous sites to form a 
“code” that determines the biological response. The most well-know example of this 
case is the histone code, in which histone tails are subject to modifications by 
acetylation, phosphorylation, methylation and ubiquitylation, and which has a 
fundamental role in regulating access to DNA [5,6].  
The N-terminal tails of histone are disordered in isolated histone proteins  [7] 
and in the crystal structure of the nucleosome core particle [8]. The intrinsic disorder 
and the inherent flexibility in these regions are probably essential for their function: 
they leave the side chains exposed for modification by several different enzymes, for 
example acetyltransferase and deacetylases, methylases, and ubiquitin ligases, and 
provides the flexibility that is needed to allow adaptation to the varying 
conformational requirements of the active sites of these enzymes. 
A number of examples of domains that are unstructured in solution but which 
become structured upon binding to their target have been noted. For example, several 
target proteins of β-catenin are intrinsically unstructured and fold upon binding to the 
extended scaffold presented by the armadillo repeat region of β-catenin. The 
cytoplasmic domain of E-cadherin is unstructured in solution [9], but becomes 
structured on binding to β-catenin [10] . 
Many natively unfolded proteins require a metal ion or metal-containing 
cofactor. Signaling events that rely on Ca2+ are dependent on changes in protein 
structure induced by the binding of Ca2+. Calcineurin, a protein with essential disorder, 
is a calcium/Calmodulin-activated serine/threonine phosphatase involved in both 
calcium and phosphorylation signaling pathways [11]. Often metalloproteins are 
unfolded in the apo state, i.e. their folding is linked to the binding of metal ions or 
cofactors. Examples include c-type proteins [12] and Ferredoxins [13]. While in vitro 
such apo proteins can be reconstituted, it is believed that under cellular conditions 
accessory proteins are required for the molecule to attain its tertiary fold. It should be 
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noted, however, that there are proteins that retain their tertiary structure in the absence 
of their metal cofactor, such as Cupredoxins [14] and Rubredoxins [15]. 
 Several databases and bioinformatic tools have been developed to predict 
naturally unstructured regions using amino acid sequence information [16,17]. The 
sequence–structure relationships indicate that disorder is an encoded property, and the 
predictions strongly suggest that proteins in nature are much richer in intrinsic disorder 
than are those in the Protein Data Bank. Recent predictions on 29 genomes indicate 
that proteins from eucaryotes apparently have more intrinsic disorder than those from 
either bacteria or archaea, with typically >30% of eucaryotic proteins having 
disordered regions of length ≥ 50 consecutive residues.  The high proportion of these 
sequences in the genomes of all organisms studied to date argues for important, as yet 
unknown functions, since there could be no other reason for their persistence 
throughout evolution. 
 Disorder in protein structures can be either local or global. Locally disordered 
regions are common and have been observed in numerous X-ray and NMR structures 
of proteins. In some of these cases their disordered regions have been linked to 
biological function. 
Interestingly, several partially unfolded intermediates between the ordered state 
and the random coil have been observed. These folding intermediates exhibit side-
chains with motional characteristics like those of the random coil but with backbone 
secondary structure like that of the ordered state. Ptitsyn et al. proposed a model to 
accommodate these observations [18]. In this model the protein converts from an 
ordered state into a form having characteristics similar to liquids. For example, the 
protein’s side-chains go from rigid to non-rigid packing, while its secondary structure 
remains almost unchanged and the overall shape of the molecule remains compact. 
Furthermore, Ptitsyn and Crane- Robinson coined the term “molten globule” [19] to 
describe this liquid-like, partially folded state. There has been considerable uncertainty 
regarding the molten globule hypothesis. However, many of the critics now largely 
accept the term molten globule, if not all of the details of the original proposal. 
 Clearly the assumption that a folded three-dimensional structure is necessary for 
function needs to be re-examined [20]. 
Dunker and co-workers proposed “The Protein Trinity Hypothesis” [21]. In this 
view, in terms of their structure, native proteins can be defined as being in one of three 
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states: the solid-like ordered state (folded), the liquid-like collapsed disordered state 
(molten globule), or the gas-like extended-disordered state (random coil). Function is 
then viewed to arise from any one of the three states or from transitions among them. 
Clearly the role of disorder in determining protein activity in organisms has to be 
evaluated when studying protein function. Therefore, in the frame of obtaining insight 
into the structure-function relationship of proteins, it is necessary for structural 
biologists to give increased attention to the importance of intrinsic disorder and 
functional flexibility in proteins.  
On the other hand, there are many cases in which flexibility may be a 
disadvantage to the cell and in which misfolding events lead to malfunctioning of 
living systems. There is increasing evidence that neurodegenerative conditions are 
correlated with misfolding of key cellular proteins and these must be structurally 
dissected to reveal potential therapeutic avenues. For example, amyloid diseases, such 
as Parkinson’s  disease, Alzheimer's disease and the prion diseases (BSE or ``mad 
cow'' disease), are characterized by the deposition of protein plaques that appear to 
arise from the misfolding of conformationally flexible proteins normally found in the 
brain and other tissues [22,23].  
The pathological hallmark of Parkinson’s disease (PD) is the presence of 
intracellular inclusions, Lewy bodies (LB), and Lewy neurities, in the dopaminergic 
neurons of the substantia nigra and several other brain regions. Insoluble alpha-
synuclein (AS) constitutes the main component of LB. AS is a neuronal protein 
localized in the presynaptic terminals in mammalian brain that is natively unstructured 
[24] but adopts a β-stranded conformation in the fibrillar aggregated of the LB of PD 
[25] and in other neurodegenerative synucleinopathies. The misfolding and 
dysfunction of alpha-synuclein, is self-assembly and the resulting amyloid formation 











It is well established that a number of metal ions are essential to life, while 
other metal ions are poisonous to living organisms, even when present at very low 
concentrations. Sometimes the same element may be beneficial or deleterious, 
depending on its speciation [27]. 
Metal-ions concentration in cells must be maintained within proper ranges. If the 
concentration of a given essential metal is too low, processes that need to use that ion 
will be adversely affected and the organism can suffer from metal ion deficiency. On 
the other hand, once the concentration of a given metal ion is higher than a minimal 
threshold, there will be enough of that ion to fulfill its biological functions. The 
concentration cannot be increased indefinitely without adverse consequences, 
however. Above an upper threshold the effects of metal ion toxicity will arise. For 
example, when a metal ion binds to an inappropriate site, it might compete with other 
beneficial metal ion for that site; or there might be undesirable reactivity of the metal 
ion when it is not properly controlled in its normal binding sites. On the other hand, 
some metals have no known or presumed biological function. When present in cells, 
they may be both innocuous or toxic. 
Homeostasis, the maintenance of the concentration of beneficial metal ions in the 
correct range, and detoxification, the removal of toxic concentrations of non-beneficial 
metal ions, require balance among the processes of metal ion uptake, utilization, 
storage and excretion. As noted above, metal ions not utilized in biological systems 
can be toxic, often because they tend to bind non-specifically, but with high affinity, to 
certain types of sites. Because of this tight binding, which is often a consequence of 
kinetic inertness, these metals may bind to sites where they inhibit some normal 
processes in such a manner that they are not easily removed and excreted. Other 
possible causes of metal ion toxicity include the formation of insoluble salts in 
biological fluids, participation in hydrolytic reactions that degrade biopolymers or 
redox chemistry that produces damaging by products, such as hydroxyl radicals. 
Cell activity maintains the concentration of essential metal ions by a specific 
metabolic pathways. There exist specific pathways involving proteins (transporters, 
metallochaperones) which protect and guide the metal ions through the cytoplasm, 
ultimately transferring the ions to specific partners proteins. It is becoming clear that 
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both the transporters and the metallochaperone proteins employ atypical coordination 
chemistry relative to the enzyme that ultimately incorporate the metal as a cofactor. 
Intracellular sequestration of metals is based on a sequence of cellular events 
involving a cascade of different ligands with increasing metal binding strengths. In 
addition, as already mentioned, some metal ions are toxic, therefore detoxification and 
resistance systems that employ a variety of mechanisms to rid the cell of these 
potentially lethal toxins have evolved. In most cases, the expression of such resistance 
system is controlled at the level of transcription by metal sensor proteins that “sense” 
specific metal ions via their direct coordination. It is the direct binding of inducing 
metal ions that allows for a change in the regulatory function of the metal sensor 
protein. 
As a conclusion, cells manage metal-proteins acquiring ions that are in deficiency, 
while exporting or sequestering those that are in surplus or toxics. The beneficial 
intracellular concentration of metals is maintained by strictly regulation in the 
expression of metalloproteins involved in specific metal uptake, export or storage. 
Metalloproteins perform a variety of functions, which can be classified into five basic 
types, according to the model proposed by Holm et al. [28]: 
 
I. structural – configuration (in part) of protein tertiary and/or quaternary structure; 
II. storage – uptake, binding and release of metals in soluble form; 
III. electron transfer – uptake, release and storage of electrons; 
IV. dioxygen binding – uptake, release and storage of oxygen; 
V. catalytic – substrate binding, activation and conversion; 
 
where V is an extensive class subdivided by the type of reaction catalyzed 
(dismutases, oxidases and oxygenases, nitrogenases and hydrogenases, 
oxotransferases, hydrolases, and others).  
Recent discoveries have identified proteins that do not fit within these categories.  For 
example, biochemical and structural data have revealed a new class of metal-binding 
proteins called, metallochaperones, as mentioned above, which function as 





1.3 Aims and Topics of the Research 
 
 The work carried out over three years of doctoral studies has been devoted to 
the structural and dynamic characterization by NMR spectroscopy of metalloproteins 
or their specific metal-binding domains in solution.  
Part of these studies were focused on the conformational and dynamic characterization 
of the calcium-protein Calmodulin and on its functional implications.  
Disorder plays an important role in this protein. CaM has two globular 
domains, each with 2 EF-hands that bind calcium. The connecting linker was 
crystallized as a rigid helical structure [31], while the solution structure revealed that 
part of this interdomain helical rod melts into a flexible linker [32], thus enabling CaM 
to wrap around its target. This limited disorder may account for the significant 
plasticity observed within the globular domains when they bind to different targets. 
The conformation and functional significance of this linker region has been the subject 
of an intensive debate. Indeed, the flexibility of this linker allows for the reciprocal 
reorientation of the two domains of CaM. 
We decided to investigate the conformational space sampled by CaM. 
To this purpose we developed a novel approach exploiting the use of long-range 
constraints. Particularly, we searched favored orientations of the two domains with 
respect to each other by using advanced NMR techniques supplied by a 
paramagnetism based strategy. The use of lanthanides as substitutes for the calcium 
centers, allowed us to exploit long-range restraints, such as pseudocontact shifts (PCS) 
and residual dipolar coupling (RDC) for structural and dynamical analysis. 
The results found, by the use of a novel approach, try to address a long-standing 
puzzle and provide new structural information on the characterization of the 
conformational space sampled by the domain reorientation of CaM (chapter  3,4). 
CaM is known to bind a number of target peptides and proteins. We became 
interested in the binding of a non-typical target: an unfolded protein. This polypeptide 
was alpha-Synuclein, a pre-synaptic protein that is implicated as a possible causative 
agent in the pathogenesis of Parkinson’s disease [22].  
Disorder in this protein may be functional. Free wild-type AS is largely 
unfolded in solution, but exhibits a region with a preference for helical conformations 
that may be important in the aggregation of AS into fibrils [33]. Previously, it was 
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shown by crosslinking experiments that CaM forms a complex with AS in the 
presence and in the absence of calcium [34]. Therefore, we set out to analyze this 
interaction by NMR and we tackled the task of understanding the nature of the CaM-
AS interaction at the molecular level, and tried to relate it with its possible 
physiopathological effects (chapter  5,6). 
A second fascinating part on my PhD work is focused on the structural 
characterization by multidimensional NMR and other spectroscopic techniques as well 
as potentiometric studies of specific binding sites of nickel ion Ni(II) to the Cap43 
protein and to histone H4 protein . 
Cap43, a novel gene induced by a rise in free intracellular Ca2+ following nickel 
exposure, encodes its protein namesake with molecular weight of 43.000 Da [35,36]. 
The role of this protein, still unknown, is perhaps related, like other stress responsive 
proteins, with a detoxification and protection of cell against oxidative stress induced 
by metals [37,38]. In this view, Cap43 protein can be examined to determine its 
behavior in binding nickel ions to neutralize their potential toxicity (chapter 7,8).  
In the same way, the study of the interactions of histone H4 or histone model peptides 
with nickel ions, and their subsequent effects, i.e. the dramatic change in the 
conformation upon metal ion complexation, is carried out  in order to contribute to the 
elucidation of the mechanism of toxicity and carcinogenicity of  nickel compounds 
(chapter 9). 
In fact, it is clear now that histones, basic proteins that play an important role in 
compression and organization of DNA,  are also fundamental, integral and dynamic 
components of  the machinery responsible for regulating gene transcription [39], and 
the impairment of their functions by interaction with nickel ions can lead to cancer 
promotion and progression. 
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PROTEIN STRUCTURE  DETERMINATION BY SOLUTION NMR 
 
An overview on a general assignment strategy for structure determination and the 










2.1 NMR  for High Resolution Structure Determination 
 
 The increasing importance of NMR as a method for structure determination 
of biological macromolecules is manifested in the steadily rising number of NMR 
structures that are deposited in the Protein Data Bank [1]. In October 2005, there 
were a total of 4825 files available from the PDB with Cartesian coordinates of 
proteins, nucleic acids and macromolecular complexes that have been obtained by 
NMR techniques.  
Until 1984 structural information at atomic resolution could only be 
determined by X-ray diffraction techniques with protein single crystals [2]. The 
introduction of nuclear magnetic resonance spectroscopy as a technique for protein 
structure determination [3] has made it possible to obtain structures with comparable 
accuracy but in a solution environment. 
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In fact the highest quality NMR structures have accuracies comparable to 
2.0–2.5 Å X-ray crystal structures. Although atomic positions in high-resolution 
crystal structures are more precisely determined than in the corresponding NMR 
structures, the crystallization process may select for a subset of conformers present 
under solution conditions. For example, while high-quality NMR structures typically 
exhibit root mean square (RMSD) deviations of backbone and heavy atoms 
(excluding those of surface side chains) of 0.3–0.6 Å and 0.5–0.8 Å, respectively, 
analysis of a set of high-resolution X-ray crystal structures of bovine pancreatic 
trypsin inhibitor determined in different crystal forms [4] indicates similar variations 
of 0.2–0.6 Å in backbone atom positions due to preferential selection of distinct low 
energy conformers in the crystallization process. 
The NMR method for the study of molecular structures depends on the 
sensitive variation of the resonance frequency of a nuclear spin in an external 
magnetic field with the chemical structure, the conformation of the molecule, and the 
solvent environment [5]. The dispersion of these chemical shifts ensures the 
necessary spectral resolution, although it usually does not provide direct structural 
information. 
 Different chemical shifts arise because nuclei are shielded from the 
externally applied magnetic field to different extent depending on their local 
environment. Three of the four most abundant elements in biological materials, 
hydrogen H, carbon C and nitrogen N, have naturally occurring isotopes with nuclear 
spin ½ , and are therefore suitable for high-resolution NMR experiments in solution. 
The proton (1H) has the highest natural abundance (99±98%) and the highest 
sensitivity (due to its large gyromagnetic ratio) among these isotopes, and hence 
plays a central role in NMR experiments with biopolymers. Because of the low 
natural abundance and low relative sensitivity of 13C and 15N (1±11% and 0±37%, 
respectively) NMR spectroscopy with these nuclei normally requires isotope 
enrichment. This is routinely achieved by overexpression of proteins in isotope-
labelled media. Structures of small proteins with molecular weight up to 10 kDa can 
be determined by homonuclear 1H NMR. 
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Heteronuclear NMR experiments with 1H, 13C and 15N [6] are indispensable for the 
structure determination of larger systems [7-8].  
However, NMR is not a microscope with atomic resolution that would 
directly produce an image of a protein. Rather, it is able to yield a wealth of indirect 
structural information from which the three-dimensional structure can only be 
uncovered by extensive calculations. The pioneering first structure determinations of 
peptides and proteins in solution [9-13] were year-long struggles, both fascinating 
and tedious because of the lack of established NMR techniques and numerical 
methods for structure calculation, and hampered by limitations of the spectrometers 
and computers of the time. Recent experimental, theoretical and technological 
advances and the dissemination of the methodological knowledge, have changed this 
situation decisively. Today, with a sufficient amount of a purified, water-soluble, 
monomeric protein with less than about 200 amino acid residues, its three-
dimensional structure in solution can be determined routinely by the NMR method, 
following the procedure described in the classical textbook of Wüthrich [3] and 















Fig. 2.1 Outline of the procedure for protein structure determination by NMR 
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The determination of a NMR solution structure may be dissected into six major parts: 
 
(I) At the outset of the NMR study, a suitable sample, usually about 500 µL of a 1 
mM protein solution is prepared. If the molecular weight of a protein exceeds ~10 
kDa, enrichment with 13C and 15N isotopes is required in order to resolve spectral 
overlap in 1H-NMR spectroscopy. Due to the availability of high-yield over-
expression systems, stable isotope labeling has become routine. 
(II) Subsequently, this sample is used to record a set of multidimensional NMR 
experiments, typically at temperatures around 30 ºC, which provide, after suitable 
data processing, the NMR spectra. 
(III) These allow determination of (nearly) complete sequential NMR assignments, 
the measurement of resonance frequencies (chemical shifts) of the NMR active spins 
in the protein. 
(IV) The resulting conformation-dependent dispersion of the chemical shifts is a 
prerequisite for deriving experimental constraints from various NMR experiments 
(such as NOE, scalar coupling, and dipolar coupling data) for the NMR structure 
calculation. The double arrow between steps (IV) and (V) indicate that the analysis 
of structural constraints and the calculation of NMR structures is generally pursued 
in an iterative fashion.  
(V) Iterations involving structure calculations and identification of new constraints 
are carried out until the overwhelming majority of experimentally derived constraints 
is in agreement with a bundle of protein conformations representing the NMR 
solution structure. Conformational variations in the bundle of structures reflect the 
precision of the NMR structure determination.  
(VI) Finally, the NMR structure can be refined using conformational energy force 
fields, which in essence reflect our current knowledge about conformational 






2.2 Heteronuclear Multidimensional NMR Experiments 
 
The introduction of the three and four-dimensional NMR experiments [14-18] 
and the availability of 13C, 15N-labelled proteins [19-29] allow one to assign the 
proton, nitrogen and carbon chemical shifts of proteins and protein-complexes with 
molecular weights above all 25 kDa and to determine their structures in solution [30-
33]. The resonance assignment of singly (15N or 13C) labelled proteins using 3D 
experiments [34] is basically an extension of Wüthrich’s strategy which exclusively 
relies on homonuclear 1H NMR experiments.  
The assignment strategy for proteins that are not isotopically enriched [35] 
makes use of a combination of COSY (COrrelation SpectroscopY), TOCSY (Total 
Correlation SpectroscopY) and NOESY (Nuclear Overhauser Effect SpectroscopY) 
or ROESY ( Rotational Overhauser Effect Spectroscopy) spectra. 
The spin systems attached to each HN are identified in the COSY and TOCSY 
spectra. NOESY or ROESY are used for the sequential assignment of the individual 
spin systems. The establishing of the sequential connectivity relies on the occurrence 
of the resonance frequency of the Hα(i) proton of amino acid (i), which is observed 
in the HN(i), Hα(i) cross peak in the COSY (TOCSY) spectrum and in the HN(i+1), 
Ha(i) cross peak in the NOESY spectrum. Especially in α-helical proteins the 
sequential connectivity is also supported from HN(i), HN(i+1) cross peaks in the 
NOESY spectrum. Resonance overlap becomes so severe in the 2D spectra of 
proteins with more than 80 amino acids, that it is often impossible to identify 
adjacent spin systems by utilizing only a single common resonance frequency of the 
connecting cross peaks.  
In 3D assignment experiments, each cross peak is labelled by three 
frequencies rather than by two frequencies as in 2D experiments. Using 15N labelling 
it is then possible to resolve the resonance frequencies of the amide protons 
according to the 15N chemical shift of the attached amide nitrogens. This is done in 
3D 15N,1H-HSQC-TOCSY [36-39] and 3D 15N,1H-HSQC-NOESY [34, 40-44] 
experiments. While this facilitates the identification as well as the sequential 
assignment of the spin systems, the sequential connectivity still relies mainly on the 
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common chemical shift of the Hα(i) proton, which can introduce ambiguities. In 
order to resolve overlapping Hα chemical shifts, 3D HNHA spectra can be recorded 
on a 15N-labelled sample. However, the use of the conformationally dependent NOE 









Fig. 2.2  Spin system of the peptide backbone and the size of the 1J and 2J coupling 
constants that are used for magnetization transfer in 13C-, 15N-labelled proteins. 
 
 
More recently, new methodological developments have been introduced. 
 They  are a combinations of 3D experiments that including the chemical shifts of 
side-chain carbon and proton spins to achieve the sequential assignment. 
The nomenclature for these triple resonance experiments reflects the 
magnetization transfer pathway of the experiments. Nuclei that are involved in 
magnetization transfers form the name of an experiment. Spins, whose chemical 
shifts are not evolved are put in parentheses. For an out-and-back type experiment 
[45], where magnetization of a spin is transferred to a remote spin and then brought 
back the same way, only the first half of the magnetization transfer is used for its 
name. For example, the out-and-back experiment that transfers magnetization from 
the amide proton (HN) via the amide nitrogen (N) to the carbonyl C′(CO) of the 
previous residue is called HNCO. If another magnetization transfer step to the Cα 
(CA) of the previous residue is included and the corresponding Cα chemical shift is 
recorded, the experiment is referred to as H(N)COCA. The parentheses indicate that 
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magnetization is only transferred via the nitrogen spin, without chemical shift 
evolution taking place.  
The strategy for resonance assignment originally proposed by Bax’s group 
employs the 3D experiments [46-50] which exclusively correlate the resonances of 
the peptide backbone: HN(i), N(i), Cα(i), Hα(i), Cα(i-1) Hα(i-1), C′ (i) and C′ (i-1). 
Further developments involved including the chemical shifts of side-chain 
carbon and proton spins to achieve the sequential assignment. In these experiments 
chemical shifts of sidechain resonances are correlated to the amide proton by 
combinations of the 3D experiments CBCA(CO)NH [51] and CBCANH [52] (fig. 
2.3). Information about the chemical shifts of the Cα and Cβ carbons is especially 
valuable for the assignment process, since they are characteristic of the different 
types of amino acids and can therefore help to position a sequentially connected 
stretch of amino acids within the known primary sequence of the protein [53]. From 
the combination of CBCA(CO)NH and CBCANH experiments the backbone 
resonance assignments and the sequential connectivities can be obtained. These 
experiments will be sensitive enough for proteins < 130 residues and provide the Cα 
and Cβ chemical shifts to establish the sequential link between neighboring residues. 
Further, the Cα and Cβ chemical shifts provide important information about the 
amino acid type and the secondary structure. In addition to sequential assignments, 









Fig. 2.3   a) The CBCANH experiment shows the correlations of Ni and HNi to both 
intra-residual Cαi and Cβi, as well as sequential correlations to the Cαi-1 and Cβ i-1  of 
the previous residue; b) the CBCA(CO)NH experiment only shows the correlations 












Fig. 2.4 Sequential assignment using CBCANH (a) and CBCA(CO)NH (b) spectra. 
 
 
 The Hα/β and Cα/β chemical shifts of the side chains are then used to link 












Fig. 2.5 The HCCH-TOCSY experiment provides nearly complete 
assignments of all aliphatic 1H and 13C resonances. In this experiment the 
magnetization is transferred via direct 1J coupling from a sidechain (or backbone) 
proton to the direct attached carbon atom, to the neighboring carbon atoms and 
finally to their attached protons. 
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After the assignment of all or nearly all resonances of a protein, experiments 
for the extraction of structural parameters are analyzed. The most important 
parameter for NMR-based structure determination are 1H, 1H distances which are 
derived from NOE intensities. With increasing size of the molecules, overlap of cross 
peaks becomes a problem also for the extraction of NOE intensities and internuclear 
distances from 2D NOESY spectra. This overlap can be removed by the introduction 
of additional frequency dimensions [34]. Resolving the NOESY spectrum along a 
heteronuclear dimension yields a large gain in resolution, while the number of peaks 





2.3 Constraints for Protein Solution Structure Determination 
 
 The solution structure is obtained by measuring a sufficient number of 
structural constraints. These are structural parameters that can be either derived from 
NMR processed data or acquired directly. Various types of structural constraints can 
be obtained by exploiting interactions between nuclei of the molecule. The structural 
information depends on the constraint type. It is possible to extract nuclear-nuclear 
distances (generally between hydrogen atoms), the reciprocal orientation of chemical 
bonds and internuclear vectors (dihedral angles) or the orientation relative to a 




2.3.1 Nuclear Overhauser Effects 
 
The NMR method for protein structure determination relies on a dense 
network of distance restraints derived from nuclear Overhauser effects (NOEs) 
between nearby hydrogen atoms in the protein [3]. NOEs are the essential NMR data 
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to define the secondary and tertiary structure of a protein because they connect pairs 
of hydrogen atoms separated by less than about 6 Å in amino acid residues that may 
be far away along the protein sequence but close together in space.  
The NOE reflects the transfer of magnetization between spins coupled by the 
dipole-dipole interaction in a molecule that undergoes Brownian motion in a liquid 
[54-56]. The intensity of a NOE, i.e. the volume V of the corresponding cross peak in 
a NOESY spectrum [55,57], is related to the distance r between the two interacting 
spins by  
 
(1) V = <r–6>f (τc)   
 
The averaging indicates that in molecules with inherent flexibility the 
distance r may vary and thus has to be averaged appropriately. The remaining 
dependence of the magnetization transfer on the motion enters through the function f 
(τc) that includes effects of global and internal motions of the molecule. Since, with 
the exceptions of the protein surface and disordered segments of the polypeptide 
chain, globular proteins are relatively rigid, it is generally assumed that there exists a 
single rigid conformation that is compatible with all NOE data simultaneously, 
provided that the NOE data are interpreted in a conservative, semi-quantitative 
manner [3]. 
More sophisticated treatments that take into account that the result of a NOESY 
experiment represents an average over time and space are usually deferred to the 
structure refinement stage [58]. 
In principle, all hydrogen atoms of a protein form a single network of spins, 
coupled by the dipole-dipole interaction. Magnetization can be transferred from one 
spin to another not only directly but also by 'spin diffusion', i.e. indirectly via other 
spins in the vicinity [55,59]. The approximation of isolated spin pairs is valid only 
for very short mixing times in the NOESY experiment. However, the mixing time 
cannot be made arbitrarily short because (in the limit of short mixing times) the 
intensity of a NOE is proportional to the mixing time. In practice, a compromise has 
to be made between the suppression of spin diffusion and sufficient cross peak 
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intensities, usually with mixing times in the range of 60-120 ms for high-quality 
structures. 
Spin diffusion effects can be included in the structure calculation by complete 
relaxation matrix refinement [60-61]. Because also parameters about internal and 
overall motions that are difficult to measure experimentally enter into the relaxation 
matrix refinement, care has to be taken not to bias the structure determination by 
overinterpretation of the data. Since the line-widths can vary appreciably for 
different resonances, cross peak volumes should be determined by integration over 
the peak area rather than by measuring peak heights. While the reliable quantification 
of NOEs is important to obtain a high-quality protein structure, one should also keep 
in mind that, according to equation (1), the relative error of the distance estimate is 
only one sixth of the relative error of the volume determination. On the basis of 
equation (1), NOEs are usually treated as upper bounds on interatomic distances 
rather than as precise distance restraints because the presence of internal motions 
and, possibly, chemical exchange may diminish the strength of an NOE [62]. In fact, 
much of the robustness of the NMR structure determination method is due to the use 
of upper distance bounds instead of exact distance restraints in conjunction with the 
observation that internal motions and exchange effects usually reduce rather than 
increase the NOEs [3]. For the same reason, the absence of a NOE is in general not 
interpreted as a lower bound on the distance between the two interacting spins. 
Upper bounds u on the distance between two hydrogen atoms are derived from the 
corresponding NOESY cross peak volumes V according to 'calibration curves',       
V=f (u). Assuming a rigid molecule, the calibration curve is  
 
6u
kV =    (2)  
 
with a constant k that depends on the arbitrary scaling of the NOESY spectrum. The 
value u obtained from equation (2) may either be used directly as an upper distance 
bound, or NOEs may be calibrated into different classes according to their volume, 
using the same upper bound u for all NOEs in a given class.  
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The constant k in equation 2 can be determined on the basis of known distances 
belonging to regular secondary structure elements, or by reference to a preliminary 
structure. 
 NOEs that involve groups of protons with degenerate chemical shifts, in 
particular methyl groups, are commonly referred to pseudoatoms located in the 
centre of the protons that they represent, and the upper bound is increased by a 
pseudoatom correction equal to the proton-pseudoatom distance. Sometimes, 
especially in the case of nucleic acid structure determination, where the standard, 
conservative interpretation of NOEs might not be sufficient to obtain a well-defined 
structure, also lower distance limits have been attributed to NOEs, either based on 
the intensity of the NOE or to reflect the absence of a corresponding cross peak in 
the NOESY spectrum. 




2.3.2 Scalar Coupling Constants 
 
Structural information about torsion angles can be obtained from scalar 
coupling three-bond 3JHX constants. The magnitude of these constants is related to 
dihedral angles subtended by the covalent bonds that connect the coupled nuclei H 
and X, where X can be 1H, 15N or 13C. According to Karplus [63], the dependence of 
the three-bond J coupling constant on the dihedral angle θ subtended by the three 
successive covalent bonds that connect the coupled nuclei is embodied in the 
relation: 
 
3J(θ) = A cos2(θ) + B cos(θ) + C   (3)  
 
where θ = torsion angle (φ, ϕ, χ etc); A, B and C are Karplus constants 
depending on the type of the torsion angle. 3JHNHα coupling constants (φ torsion 
angle) are obtained from the ratio between the intensity of the diagonal peak and that 
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of the cross-peak of the HNHA map. Through the analysis of the HNHB spectrum 
the   3JHNHα(i-1) and 3JHNHβ coupling constants (ϕ and χ torsion angles, respectively) 










Fig. 2.3  Karplus relation describing the dependence of coupling constants 3JHNHa for 




2.3.2 Hydrogen Bonds 
 
When a protein is expressed and purified in protic solvents (water-based 
buffers) the backbone amides HN are all protonated. When the protein is then 
quickly transferred to D2O-based buffer, the NH groups begin to exchange to ND. 
Under typical NMR conditions, exchange occurs within seconds for exposed 
NH groups. However, exchange may be as slow as hours or days if the NH groups 
are protected in hydrogen bonds or buried within the protein structure. Typically, an 
H-D exchange data set is collected and the amide protons remaining after a few 
hours are identified. In early stages of structure calculations, it becomes apparent 
what the hydrogen-bonding partners of these groups are. 





2.3.3 Chemical Shifts 
 
Chemical shifts are very sensitive probes of the molecular environment of a 
spin. 
However, in many cases their dependence on the structure is complicated and either 
not fully understood or too intricate to allow the derivation of reliable conformational 
restraints [64,65]. An exception in this respect are the deviations of 13Cα (and, to 
some extent, 13Cβ) chemical shifts from their random coil values that are correlated 
with the local backbone conformation [66,67]. 
13Cα chemical shifts larger than the random coil values tend to occur for 
amino acid residues in α-helical conformation, whereas deviations towards smaller 
values are observed for residues in β-sheet conformation. Such information can be 
included in a structure calculation by restricting the local conformation of a residue 
to the α−helical or β-sheet region of the Ramachandran plot, either through torsion 
angle restraints [68] or by a special potential [69] although care should be applied 













Fig. 2.4. Relation between the secondary structure and chemical shift deviations 
from random coil values of  Cα and Cβ. 
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2.3.4 PCS and RDC 
 
In the case of systems containing paramagnetic centers (like metalloproteins), 
it is possible to use the electron-nucleus interaction as a further source of structural 
information. The through-space contribution to nuclear relaxation depends on the 
distance between the metal ion (M) and the resonating nucleus (H), as the reciprocal 
of the sixth power of the distance. The contact shifts are used as constraints as they 
depend on the metal-donor-carbon-proton (M-D-C-H) dihedral angle, in the case of 
protons attached to an sp3 carbon of a ligand of the metal ion.  
The occurrence of magnetic anisotropy causes the dipolar coupling between 
the electron and the resonating nucleus not to average to zero in solution. This is 
because the electron magnetic moment changes with the orientation of the molecule 
with respect to the external magnetic field. This residual dipolar coupling provides a 
contribution to the nuclear chemical shift which is called pseudocontact shift (PCS) 
[70]. It is easily determined by measuring the chemical shift of the nuclei close to the 
metal but separated from it by enough chemical bonds that there is no unpaired 
electron spin density delocalized from the metal ion. To obtain the PCS values from 
these shifts it is necessary to subtract the corresponding shifts measured in an 
otherwise identical diamagnetic analog.  
PCS are precious long-range constraints. In fact, the contribution to the shift 
due to the through-space coupling depends on the distance between the metal ion and 
the resonating nucleus (as the reciprocal of the third power of the distance) as well as 
on the magnetic susceptibility anisotropy of the metal ion and on the polar 
coordinates of the resonating nucleus with respect to the axis system formed by the 
principal directions of the magnetic susceptibility tensor.  
PCS have been used from the early steps of structural calculations as well as 
for structure refinements. Furthermore, they provide a unique tool for the location of 
the metal ion in the protein frame, without any assumptions. As a result of the 
application of PCS, information on the magnetic susceptibility tensor of the metal 
(χmetal) is obtained. 
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The occurrence of magnetic anisotropy implies that the molecular tumbling in 
solution is not random at high magnetic fields. Instead, a partial orientation occurs. 
This provides residual dipolar couplings (RDC) [71] between nuclei, having values 
different from zero. They can be conveniently detected by measuring 15N-1H 1J (as 
well as 13C-1H 1J) at variable magnetic fields. Such contributions can yield powerful 





2.4 Structure Calculation 
 
Using NMR (distances and angles) constrains, calculation programs fold a 
random generated 3D structure in order to maximize the agreement between the 
structure and the structural constrains. As input for the programs the primary 
structure of the protein is taken, and all bond lengths and angles are taken fixed to 
their ideal values or allowed to deviate only slightly from these values. As the 
structural constrains used for calculations are not strict values and in some regions of 
protein the experimentally number constrains obtained is not sufficient to determine 
the local conformation, several different conformations may be calculated to satisfy 
the imposed constrains.  
In general, it is preferred to have a large number of constraints of different 
types and to use a relatively large tolerance in order to minimize effects arising from 
miscalibration of the constraints. Indeed, if protocols are developed for applying 
new, non-classical constraints to structure calculations, improvement in the structure 
accuracy and precision can be achieved. In particular, inclusion of non-classical 
constraints derived from paramagnetism produces a more precise structure in the 
region surrounding the metal ion, and increases the accuracy. 
The structural indetermination is a physical feature of the protein. 
The NMR constraints only reflect the average structure. A NMR structure is thus 
represented by a family of conformers, usually composed by 20 to 50 members, 
 30
which are in good agreement with the structural constrains imposed. The precision of 
the structure is measured by the root-mean-square-deviation (RMSD) of the 
coordinates of the protein atoms for each conformer of the family from the mean 
structure. 
The local RMSD value varies along the polypeptide chain. High local RMSD values 
can be due to the lack of experimental constraints, to actual disorder of the structure 
in solution or both. The accuracy of the structure is measured by an average target 
function of the family. 
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3.1 Ca2+-binding Proteins  
 
Calcium (Ca2+) is a intracellular secondary messenger responsible for controlling 
and regulating a wide variety of cellular processes, such as nucleotide metabolism, 
muscle contraction, cellcycle control, differentiation and signal transduction.  
The cellular free Ca2+ concentration of living cells is tightly controlled within 
the range of 10-7 – 10-5 M via intricate Ca2+ influx and efflux mechanisms [1,2]. Upon 
external stimulation, the intracellular Ca2+ concentration transiently increases to ~ 10-5 




















Fig. 3.1       Mechanisms of calcium signalling 
Cell stimulation by agonists activate the formation of second messengers that induce 
the release of Ca2+ stored in the endoplasmic/sarcoplasmic reticulum (ER/SR) 
through the IP3 receptor (IP3R), the ryanodine receptor (RyR), the NAADP receptor 
(NAADPR) or the sphingosine 1-phosphate binding site (S1P-R). In addition, 
agonists stimulate the entry of extracellular Ca2+ through plasma membrane 
channels. Most of the cytosolic Ca2+ is bound to buffers, and only a small percentage 
binds to effectors and activates cellular functions. Ca2+ removal is mediated by 
various pumps and exchangers, including the Na+/Ca2+ exchanger (NCX) and the 
plasma membrane Ca2+ ATPase (PMCA) that extrude Ca2+ from the cytosol and the 
sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) that pumps Ca2+ back to the 
ER/SR. During the Ca2+ signal mitochondria sequester Ca2+ through an uniporter that 
might be then released slowly into the cytoplasm through the NCX or the 




The Ca2+ signaling pathway involves numerous CBPs, which can be divided 
into Ca2+ buffers and Ca2+ sensors, on the basis of their main functions. Cytosolic 
buffers are involved in shaping both the amplitude and duration of Ca2+ signals . 
Buffers also limit the spatial spreading of Ca2+ signals. This is particularly important 
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in neurons that contain high concentrations of buffers such as Parvalbumin and 
Calbindin, which ensure that Ca2+ signals are largely confined to synapses. 
 The second class, Ca2+ sensors  proteins, comprises proteins that bind to Ca2+ 
for the specific purpose to decode its information, and doing so their real task is that 
of transmitting suitably processed Ca2+ signals to the desired targets. 
The more common sensors are Troponin C and Calmodulin that respond to an 
increase in Ca2+ by activating diverse processes. 
Troponin C has a limited function to control the interaction of actin and myosin 
during the contraction cycle of cardiac and skeletal muscle. Calmodulin (CaM) is 
used more generally to regulate many processes such as the contraction of smooth 
muscle, gene transcription, ion channel modulation and metabolism. The same cell 
can use different sensors to regulate separate processes. In skeletal muscle, for 
example, Troponin C regulates contraction whereas CaM stimulates the 
phosphorylase kinase to ensure a parallel increase in ATP production. 
The binding of  Ca2+ results in conformational changes of these CBPs, thus enabling 
these proteins to interact with their respective partner proteins and enzymes. The 
formation of complexes between CBPs and their targets induces further 
conformational changes in both components of the complexes, thereby allowing 
functional regulation of the targets. Therefore, CBPs play pivotal roles in            




3.2 EF-hand Motif 
 
Calcium interacts with a very large number of proteins, but the variety of 
configurations of calcium binding sites is rather limited. The most common among 
these is the EF-hand motif. 
The name EF-hand was devised by Kretsinger and Nockolds as a graphical 








Fig. 3.2     The EF-hand Ca2+-binding motif 
In each EF-hand motif, two alpha-helices, oriented at a approx. 90° angle, flank a 12 
amino acid-containing loop. The Ca2+ ion is coordinated by seven oxygen ligands in 
a pentagonal bipyramid arrangement; five amino acid residues at positions X,Y,Z,-X 




The canonical sequence of the EF-hand motif is rather short (about 30 
residues) and consists of a helix-loop-helix motif characterized by a binding loop of 
12 residues with the pattern +X•+Y•+Z•-Y•-X••-Z, where ±X; ±Y; and ±Z are the 
ligands that participate in the metal coordination and the dots represent intervening 
residues. At positions X and Y, we usually find the sidechains of aspartic acid or 
asparagine; the sidechains of aspartic acid, asparagine or serine are found at Z and a 
peptide carbonyl oxygen lies at –Y. –X is usually a water molecule and –Z is a 
conserved bidentate ligand, glutamic acid or aspartic acid. 
The two helices are arranged similar to the extended thumb and index finger 
of a hand. 
This relatively simple structural motif can accommodate calcium and 
magnesium with differences in the geometry of the coordination and in the specific 
affinity [4]. Magnesium is usually bound by six ligands in an octahedron, whereas 
seven ligands at the vertices of a pentagonal bipyramid coordinate calcium. 
The function of some EF-hand proteins, such as Parvalbumin in muscle 
physiology and CaM in the cytosol, depends on the difference in affinity for calcium 
and magnesium [5]. The Ca2+-binding affinities of EF-hand proteins vary 
substantially (Kd = 10-4-10-9 M) and are amino acid sequence dependent, especially 
with regard to the 12-residue consensus loop sequence that provides all the amino 
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acids that directly ligate a Ca2+ ion [6]. In many proteins, EF-hands exist as a pair, 
with a short antiparallel β-sheet interaction between the two Ca2+-binding loops. 
Zhang et al. showed that concerted movement of the helices in these EF-hand pair is 
crucial for the cooperativity of Ca2+-binding [7].  The EF-hand motif has been 
detected in a number of small proteins (e.g. CaM or S100) and within domains of 
much larger complex proteins (i.e. Myosin or Calpain).  
In most known cases, EF-hand motifs occur in adjacent pairs: Parvalbumin 
and S100 proteins represent the minimal motif. The Eps15 homology (EH) domain is 
also formed by a pair of EF-hands and the structures of several EH domains of Eps15 
show a fold similar to that found in S100 proteins. Proteins containing four EF-hand 
motifs usually have two domains, each formed by a pair of EF-hands, separated by a 
flexible linker, which can be extended in the classical dumbbell structures of CaM 
and Troponin C. One exception to the rule of EF-hand pairing is Calpain, which has 
five EF-hand motifs in the C-terminal part of its large subunit. However, Calpain 















Fig. 3.3   Ribbon representation of the structures of a number of proteins of the 
EF-hand family: A) Myosin, B) Troponin C, C) Calmodulin, D) Calbindin D9K , E) 





3.3 Domain Organization and Functional Roles 
 
The concept of regulatory and structural domains was first introduced for 
Troponin C, in which the high-affinity carboxy-terminal domain (structural) always 
binds Ca2+ in the muscle cell, and the low-affinity amino-terminal domain 
(regulatory) triggers the Ca2+ signal leading to muscle contraction [8]. EF-hand 
proteins with regulatory roles are often termed Ca2+-sensor proteins, whereas those 
involved in Ca2+ buffer and transport functions are termed Ca2+-buffer proteins [9]. 
Most EF-hand proteins consist of single, or multiple, pairs of the helix-loop-helix 
motif. Typically, a pair of EF-hand motifs forms a globular domain, while a protein 
containing four motifs is composed by two domains that can be either structurally 
independent, as observed in the structures of CaM and Troponin C, or well packed, 
resulting in a single oval shape, as seen in the structure of Recoverin. Some domains 
have a single, functional Ca2+-binding site, for example, the amino- and carboxy-
terminal domains of Recoverin and Myosin light chains.  
EF-hand proteins undergo conformational changes upon binding of Ca2+. This event 
is a crucial step in many Ca2+-dependent cellular processes. 
The high number of three-dimensional structures of various EF-hand proteins 
have led much insights into the structure and functional relationship of this large 
family of Ca2+-binding proteins and have provided valuable information about this 
Ca2+-induced conformational change. Indeed, both the carboxy- and amino-terminal 
domains of CaM undergo large structural rearrangements upon binding of Ca2+ from 
the ‘closed’ conformation (the two helices of each EF-hand are almost anti-parallel) 
to the ‘open’ conformation (the two helices are more perpendicular) [7]. By contrast, 
Calbindin D9K, retains the Ca2+-free ‘closed’ conformation even after binding Ca2+ 
[10]. Indeed, the single domain of Calbindin D9K exhibits small conformational 
changes in response to binding of Ca2+, which may be responsible for the structural 
stability and function in buffering intracellular Ca2+. Thus, this type of domain can be 




3.4 Calmodulin : Ca2+-modulated Protein 
 
  Calmodulin  is a primary Ca2+ -receptor protein. It is a small, 148 amino 
acid residues, highly conserved protein molecule found in all eukaryotes. The protein 
is able to bind hundred of target proteins and enzymes including various protein 
kinases and phosphatases, receptors, ion-channel proteins, phosphodiesterases, and 
nitric oxide synthases [11]. These CaM targets play essential roles in a wide variety 
of cellular events such as cytoskeletal dynamics, metabolism, cell proliferation, and 
development.  
CaM consists of two similar domains, each containing two Ca2+-binding sites. 
Each metal-ion binding site is comprised of a highly conserved, continuous stretch of 
12 residues, the EF-hand helix-loop-helix motif. The residues at positions +X, +Y, 
+Z, -Y, and -X of this 12-residue loop each provide one ligand, and the side chain of 
the -Z residue supplies two oxygen ligands to each Ca2+ ion. Hence, Ca2+ forms a 












Fig. 3.4     Calcium coordination in Calmodulin 
a) The first EF-hand in CaM is used to illustrate the pentagonal bipyramidal ligation 
of the calcium ion. Oxygen atoms ligating calcium are colored black. The water 




The C-terminal domain of CaM cooperatively binds to two Ca2+ ions with a 
Kd of ~10–6 M, and the N-terminal pair of EF-hands also cooperatively binds to Ca2+ 
ions, albeit with an approximately 10-fold lower affinity [13-16]. The Ca2+-binding 
affinity of CaM falls exactly in the range of the intracellular Ca2+ concentration 
fluctuation, ensuring that the protein is capable of responding to cellular Ca2+ 
signaling. In addition, the kinetic parameters of Ca2+ binding (kon ~108 s–1 and koff 
~103 s–1), a diffusion controlled on-rate and a millisecond off-rate) allow the protein 
to respond in a timely fashion to transient cellular Ca2+ concentration fluctuations. 
Therefore, CaM is ideally suited as a cellular Ca2+ signal trigger both 
thermodynamically and kinetically. The binding of Ca2+ to CaM induces large 
conformational changes in both domains of the protein. The Ca2+-bound form of 
CaM is competent in binding with high affinity (with a Kd of ~10–8 to 10–11 M) to its 
















Fig. 3.4  Ribbon representation of  the X-ray three-dimensional structure of  Ca2+-
CaM refined at 2.2 Å resolution [12] (PDB ID code 3CLN). 
The  numbers are referred to the binding sites of calcium ions: I ,II in the N-terminal 
domain and III, IV in the C-terminal domain 
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3.5 Calmodulin  is a Highly Flexible System 
 
The crystal structure of Ca2+- CaM has shown that the protein has a dumbbell 
shape comprising an N- and a C-terminal globular domain, which are connected by a 
long (27-residues), continuous, solvent-exposed α-helix, the so-called central helix 
[12] (fig. 3.5a). The two helices in each of the four helix–loop–helix (EF-hand) Ca2+-
binding sites are almost perpendicular to each other. 
Residues 7–9 of each Ca2+-binding loop form a mini β-strand, and the two β-
strands in each domain form an antiparallel sheet structure. Other than forming the 
antiparallel β-sheet, the helices of two EF-hands pack with each other to form a 
compact, globular domain structure. In particular, extensive contacts between the 
first and fourth (helices A–D for the N-terminal domain and E–H for the C-terminal 
domain) and between the second and third helices (helices B–C and F–G) of each 













Fig 3.5 a) Ribbon representation of  the early X-ray three-dimensional structure 
(extended conformation) of  Ca2+-CaM refined at 2.2 Å resolution (PDB code ID 
3CLN); b) it shows the disorder in the central linker, between helix D and E, 
determined from small angle X-ray scattering and fluorescence energy transfer 
measurements and recently by NMR as well as by X-ray diffraction; c) NMR 
structure (closed conformation) of Ca2+-CaM complex with Calmodulin Dependent 
Protein Kinase Fragment (shown in blue colour) (PDB code ID 1CKK) 
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The structure of Ca2+/CaM, determined by X-ray crystallography showed that 
the two EF-hand pairs forming the C- and N-terminal lobes are connected by a rigid 
α-helix of 18 residues [17]. 
The length and expected rigidity of the central helix, as suggested from the 
crystal structure, does not agree well with data from small angle X-ray scattering and 
fluorescence energy transfer measurements in solution [18,19]. Additionally, it was 
shown by NMR as well as by X-ray diffraction data that the observed α-helical 
conformation of the central linker is a consequence of crystal packing [20,21].  
The connecting helix resulted to be an artifact of crystallization. When CaM is in 
solution, part of the helical rod melts into a flexible disordered linker, allowing the 
protein to wrap around its target (fig. 3.6c). 
Consequently, the N- and C-terminal lobes do not adopt a defined orientation 
relative to each other in solution, but display a tumbling motion, being held together 
by the central linker.  
CaM undergoes an additional conformational change upon binding to target proteins 
in which the two hydrophobic pocket regions of CaM are brought near to one another 
and wrap around an amphiphilic α-helix in the target. In order to accommodate this 
large conformational change, the central helix unwinds in the middle and acts as a 
flexible linker that is capable of allowing the two lobes to adopt variable orientations 
when bound to the target helix [22,23]. This helical flexibility, combined with the 
inherent deformability of the hydrophobic pockets, is thought to account for the 
ability of CaM to interact with a variety of different targets in a sequence-
independent fashion [24,25]. More generally, the prominent role that conformational 
dynamics play in both Ca2+ binding and target recognition illustrates the importance 
of structural plasticity in every aspect of CaM function. 
It is therefore apparent that CaM has ample conformational freedom in 
solution, but that the extensive experimental data available do not allow us yet to 
make reasonable deductions on the nature and variety of the most favored 
conformers. Our goal during this work of thesis was to explore the conformational 
space sampled by CaM using a advanced NMR techniques supplied by a 
paramagnetism based strategy. 
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3.6 Lanthanide Substitution as a Tool for the Structural Investigation of Human 
Calmodulin 
 
The conformational space sampled by the two-domain protein CaM has been 
explored by an approach based on four sets of NMR observables obtained on well-
defined lanthanide-substituted proteins. 
Lanthanides are known to be spectroscopic probes for calcium-binding proteins. 
They are widely employed as luminescent probes [26,27] as well as NMR probes. In 
the latter case, their paramagnetism is exploited to generate new constraints in 
solution structure determinations [28-34]. 
In view of these favorable properties, it would be desirable to have 
stoichiometrically definite and selectively substituted lanthanide-bound proteins [35]. 
Apparently, this is sometimes a difficult goal, especially in the presence of multiple 
calcium binding sites. The loop of each EF-hand contains a calcium binding site. 
Addition of lanthanides to calcium-loaded proteins sometimes provides selective 
lanthanide substitution [36], but this is not the case for vertebrate CaM [37]. 
Mutations in the sequence is therefore necessary in order to provide Ca3Ln-
derivatives with one lanthanide selectively substituted in one of the four calcium 
binding sites. The selective substitution of the calcium center in the second site of the 
N-terminal domain was obtained by using a N60D mutant, where asparagine N in 
position 60 was substituted by aspartate D,   previously tested and found to increase 
the affinity of lanthanides for this site [38]. 
To explore favored orientations of the two domains with respect to each other 
we based our approach on the exploitation of the long-range restraints that are 
imposed on the nuclear coordinates (PCS) and internuclear vector orientations 
(RDC) in one domain (C-terminal domain) by the presence of paramagnetic metal 
ions with large and different magnetic susceptibility tensor anisotropies in the other 
domain (N-terminal domain). Four sets of paramagnetic restraints were obtained on 
Tb3+- and Tm3+- substituted proteins. 
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15N,13C-enriched vertebrate N60D (Ca2)N(Ca2)CCaM was subjected to the 
standard set of 2D and 3D experiments to assign backbone and side chains, and to 




 N-terminal domain C-terminal domain 
Meaningful NOEs 1495 1225 
ϕ dihedral angles 50 43 
ψ dihedral angles 50 43 
PCS (Tb3+ and Tm3+) 125 165 









Table 3.1 Type and Number of restraints used in the Dyana Calculation 
 
 
Experiment Dimensions of acquired data Spectral width (Hz)
 t1 t2 t3 F1 F2 F3 
1H-15N-HSQC 256(15N) 1024(1H)  2500 11261  
[1H-1H]-NOESY 1024(1H) 2048(1H)  10416 10416  
CBCANH 128(13C) 48(15N) 2048(1H) 13404 3548 10416 
CBCA(CO)NH 128(13C) 48(15N) 2048(1H) 13404 3548 10416 
HNHA 128(1H) 48(15N) 1024(1H) 10416 3548 10416 
(H)CCH-TOCSY 128(13C) 80(13C) 2048(1H) 12500 12500 10416 
1H-15N-HSQC-NOESY 320(1H) 48(15N) 2048(1H) 10416 2199 10416 
1H-13C-HSQC-NOESY 128(1H) 64(13C) 1024(1H) 10416 14082 10416 
1H-15N-HSQC (PCS) 256(15N) 1024(1H)  2500 11261  
1H-15N-HSQC (JNH-split) 256(15N) 1024(1H)  2500 11261  
 
 
Table 3.2  Acquisition parameters for NMR experiments 
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The structures obtained for the two domains are in good agreement with the 
latest solution structure refined with the help of RDC [39] resulting from orienting 
media.  
N60D (CaLn)N(Ca2)CCaM derivatives with Ln = Tm or Tb were prepared, 
and an extensive assignment of both N-terminal and C-terminal peptide NH nuclei 
was performed by using a semiautomated procedure [40,41]. 
Paramagnetic lanthanides are capable of orienting the protein in high 
magnetic fields to an extent similar to that obtained by using orienting devices, and 
each lanthanide orients according to its magnetic susceptibility tensor.  
Thus, we use the PCS values also as additional constraints in the structure 
determination by the program PARAMAGNETIC DYANA [42] together with the 
obtained magnetic susceptibility anisotropy values. The resulting family of solution 
structures of the N-terminal domain of CaM containing the N60D mutation (fig. 3.6 ) 

















Fig. 3.6 Family of solution structures of the N-terminal domain of N60D CaM.  
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These magnetic susceptibility anisotropy tensors determine the frame to 
which the positions of the C-terminal domain are referred. Such positions are 
referred to as conformations of CaM, where the N-terminal domain is fixed and the 
C-terminal domain is not. The very same N-terminal tensor contributes to induce a 
partial orientation of the N-terminal domain in a magnetic field and tends to induce 
an orientation also on the C-terminal domain. Therefore, it is possible to extract 
information on the relative orientation of the C-terminal and N-terminal domains. 
 It was found that not all of the conformations are equally populated. 
 With respect to the N-terminal domain, the C-terminal domain resides in a region of 
space inscribed in an elliptical cone, in which its axis is tilted by about 30 degrees 
with respect to the direction of the N-terminal part of the interdomain helix (fig. 3.7). 
Additionally, the RDC values show that the C-terminal domain undergoes 
rotation about the axis defined by the C-terminal part of the interdomain helix.  














Fig. 3.7  Cone containing the three conformations of the C-terminal domain (only the 
first two helices are shown), which provided pseudo contact shifts and residual 




The applied procedure is of general application, as paramagnetic line 
broadenings decay with 1/r6 (r being the metal-nucleus distance), PCS decay with 
1/r3 and RDC do not decay at all with distance. Therefore, no matter how strongly 
paramagnetic the metal center is, there will always be plenty of PCS and RDC to be 
detected outside the region of excessive broadening. For broadened lines, PCS can be 
measured more accurately than RDC. Therefore, if the metal sits in one domain, large 
and meaningful PCS can still  be measured for that domain (and used to determine 
the tensor) while small but meaningful PCS and RDC can be measured for the other 
domain (and used to sample the conformational space). 
These findings are unique, both in terms of structural information obtained on 
a biomolecule that samples multiple conformations and in terms of the approach 
developed to achieve the results. The same approach is in principle applicable to 
other multidomain proteins, as well as to multiple interaction modes between two 
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The conformational space sampled by the two-domain protein
calmodulin has been explored by an approach based on four sets
of NMR observables obtained on Tb3- and Tm3-substituted
proteins. The observables are the pseudocontact shifts and residual
dipolar couplings of the C-terminal domain when lanthanide sub-
stitution is at the N-terminal domain. Each set of observables
provides independent information on the conformations experi-
enced by the molecule. It is found that not all sterically allowed
conformations are equally populated. Taking the N-terminal do-
main as the reference, the C-terminal domain preferentially resides
in a region of space inscribed in a wide elliptical cone. The axis of
the cone is tilted by 30° with respect to the direction of the
N-terminal part of the interdomain helix, which is known to have
a flexible central part in solution. The C-terminal domain also
undergoes rotation about the axis defined by the C-terminal part
of the interdomain helix. Neither the extended helix conformation
initially observed in the solid state for free calcium calmodulin nor
the closed conformation(s) adopted by calcium calmodulin either
alone or in its adduct(s) with target peptide(s) is among the most
preferred ones. These findings are unique, both in terms of struc-
tural information obtained on a biomolecule that samples multiple
conformations and in terms of the approach developed to achieve
the results. The same approach is in principle applicable to other
multidomain proteins, as well as to multiple interaction modes
between two macromolecular partners.
Calmodulin (CaM) is a paradigm case in structural biology.The following brief survey of the history of the structural and
dynamic studies on this protein serves the double purpose of
putting the present findings in proper perspective and of ac-
knowledging those pieces of previous information that were
essential to allow the present approach to be developed and to
yield novel structural information.
CaMs are two-domain proteins belonging to the large family
of EF-hand proteins (1–3). They contain 150 amino acid
residues, organized into two domains of 70 aa each and
connected by a short linker. Each domain is made up of two
special helix–loop–helix motifs (EF-hand motifs) that can bind
a calcium ion in the loop. The two loops are held close to one
another by two short antiparallel -strands forming a three-
hydrogen bond stretch of -sheet. The function of CaM in cell
cytoplasm is that of responding to sudden rises of calcium
concentration by binding up to four calcium ions in the four
EF-hand loops, by changing conformation because of metal
binding, and by thus becoming able to recognize, bind to, and
activate, a number of proteins and enzymes (1, 4–8). Early x-ray
data (9) showed the four-calcium (Ca2)N(Ca2)CCaM form (sub-
scripts N and C refer to the calcium atoms bound by the N- and
C-terminal domains, respectively) to have a dumbbell shape,
with helix 4, the last helix of the N-terminal domain, and helix
5, the first helix of the C-terminal domain, together with the
interdomain linker, forming a long continuous helical structure
(Fig. 1A). On the other hand, the protein takes up a closed
conformation, with total loss of the helical character of the
interdomain linker, when it binds to its target peptide(s) (Fig.
1B) (10–15). This binding involves the two domains getting
closer to one another and clamping the recognition peptide in
the target molecule between their exposed hydrophobic cores.
It was soon recognized that the NMR properties of
(Ca2)N(Ca2)CCaM in solution were inconsistent with the rigid
dumbbell shape observed in the early x-ray work, and that the
central part of the helix loses its helical character and allows
reciprocal reorientation of the two domains (16–20). Molecular
dynamics simulations were performed (21, 22), confirming the
flexibility of the two domains. An extended model-free analysis
characterized the relative motions as occurring on a time scale
of 3 ns, with a squared order parameter of 0.7 relative to the
x-ray conformation, at room temperature (17). When tempera-
ture was raised to 40°C, a larger interdomain motion was
observed, as a result of a doubling of the random coil residues
in the central linker (23). Disorder in the central part of the
interdomain helix was recently observed in an x-ray structure at
1.0-Å resolution (24). Finally, recent work has shown that native
calcium-loaded CaM can also crystallize in the closed confor-
mation (25).
It is therefore apparent that (Ca2)N(Ca2)CCaM has ample
conformational freedom in solution, but that the extensive
experimental data available do not allow us yet to make rea-
sonable guesses on the nature and variety of the most favored
conformers. Our approach is based on the exploitation of the
long-range constraints that are imposed on the nuclear coordi-
nates (pseudocontact shifts, pcs) and internuclear vector orien-
tations (residual dipolar couplings, rdc) in one domain by the
presence of paramagnetic metal ions with large and different
magnetic susceptibility tensor anisotropies in the other domain.
At least two metal ions are needed (26, 27) which in the present
case are Tb3 and Tm3. The approach capitalizes specifically on
the results of recent work summarized below.
(i) It has been shown that lanthanide derivatives of Drosophila
melanogaster CaM do induce appreciable pcs and rdc in the
domain not bearing the lanthanide. It has been also observed
that both pcs and rdc were sizably smaller than predicted by
assuming that the x-ray conformation was maintained in solu-
tion, consistent with the presence of multiple conformations.
The presence of a mixture of species deriving from lanthanide
binding to different calcium sites apparently prevented a deeper
analysis (28).
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(ii) An extensive series of mutants of vertebrate CaM aimed
at altering the relative affinity of lanthanide (Ln) vs. calcium in
the four metal binding sites was prepared and investigated by
NMR. The N60D mutant was found to increase the relative
affinity of calcium for the second site of the N-terminal domain
to an extent that permitted the preparation of well defined
(CaLn)N(Ca2)CCaM derivatives (29).
(iii) The solution structure of CaM has been recently refined
with an extensive use of rdc derived from an external orienting
system. The structure showed significant differences in the
helix orientations within the N-terminal domain with respect
to the atomic resolution x-ray structure, and it provided
reliable information on the orientation of internuclear vectors
within both the N- and C-terminal domains (30). Therefore
this structure is an essential starting point for the present
study. We refer to this C-terminal domain structure as the
‘‘Bax structure.’’ It should be noted that the information
derived from the rdc obtained from an external orienting
device is complicated by the fact that the orientation of each
domain is the result of the contribution from the orientation
of the other domain plus the direct and stronger orienting
effect of the external device on the domain itself (31, 32).
Materials and Methods
Protein Expression. The plasmid pET16b-CaM was used to trans-
form the BL21(DE3)gold Escherichia coli strain (Novagen) and
transformants were used for the expression of unlabeled samples
as previously described (29). 15N-labeled N60D CaM was pre-
pared as previously reported for unlabeled samples (29), except
that immediately before induction the cells were gently pelleted
and resuspended in M9 minimal medium supplemented with the
appropriate isotopically labeled nitrogen (1.2 g of 15NH4Cl per
liter) and carbon (3.5 g of [13C]glucose per liter) sources.
Bacterial cultures were induced with 0.5 mM isopropyl -D-
thiogalactoside, and the cells were further incubated at 37°C
overnight. N60D (Ca2)N(Ca2)CCaM was purified as previously
described (29).
Sample Preparation. After protein purification, NMR samples
were prepared by buffer exchange by Centricon (Millipore)
ultrafiltration with a membrane cutoff of 10,000 Da, as previ-
ously reported (29). Final conditions for NMR samples were 20
mM Mes400 mM KCl, pH 6.5. Apo N60D CaM samples were
carefully titrated up to 3 eq of Ca(II) by addition of CaCl2. NMR
samples (10% D2O) were concentrated to about 1 mM protein
solutions. N60D (Ca1)N(Ca2)CCaM samples were titrated with 50
mM solutions of analytical-grade LnCl3 (Ln  Tb or Tm). The
samples were kept at 4°C between measurements.
NMR Spectroscopy. NMR spectra were acquired on Bruker
Avance 700 and 600 spectrometers operating at 700.13 and
600.13 MHz, respectively, equipped with triple-resonance in-
verse (TXI) gradient probes. Experiments were carried out at
300 K. Quadrature detection in the indirect dimensions was used
and water suppression was achieved by means of WATERGATE
(33). Experimental parameters are listed in Table 2, which is
published as supporting information on the PNAS web site. All
spectra were processed with the Bruker XWINNMR software
package and analyzed by the program SPARKY (34).
pcs values of the Ln-substituted derivatives were obtained by
recording 1H–15N heteronuclear sequential quantum correlation
(HSQC) spectra (35) at 300 K and using a spectral width of 16
ppm and 32 ppm in the 1H and 15N dimensions, respectively. A
total of 256 increments each with 1,024 complex data points and
16 transients were collected. The recycle delays were in the range
between 0.7 s (paramagnetic derivative) and 1.5 s (diamagnetic
derivative). pcs were calculated as the difference of the nuclear
shifts between N60D (CaLn)N(Ca2)CCaM and N60D
(Ca1)N(Ca2)CCaM.
One-bond 1H–15N coupling constants were measured at 300 K
and 700 MHz by fitting a series of 1JNH-modulated HSQC spectra
(36). rdc were calculated as the difference of the fitted 1JNH between
N60D (CaLn)N(Ca2)CCaM and N60D (Ca1)N(Ca2)CCaM.
Structure Calculation. Triple-resonance experiments were used to
assign the backbone of N60D (Ca2)N(Ca2)CCaM. The backbone
resonance assignment was obtained by the analysis of triple-
resonance CBCANH and CBCA(CO)NH spectra (37, 38) per-
formed at 700 MHz. Side-chain carbon and proton assignments
were made by a (H)CCH-TOCSY experiment (39) at 700 MHz.
HNHA (40) and 1H–15N-NOESY-HSQC (41) spectra at 700
MHz allowed for torsion angle calculations. Backbone dihedral
 angles were independently derived from 3JHNH coupling
constants through the appropriate Karplus equation. More
specifically, 3JHNH values 7 Hz were constrained to  angles
between 155o and 85o and for those lower than 4.5 Hz the 
angles were constrained within 70o and 30o (40).
Backbone dihedral  angles for residue i  1 were also
determined from the ratio of the intensities of the dN(i  1, i)
and dN(i, i) nuclear Overhauser enhancements (NOEs) present
on the 15N(i) plane of residue i obtained from the 15N-edited
NOESY-HSQC. Ratio values of residue i  1 greater than one
are indicative of -sheets with  values ranging between 60o and
180o, whereas values smaller than one indicate a right-handed
-helix with  values between 60o and 20o (42).
NOEs were measured from 2D NOESY (43), 3D 1H–13C-
HSQC-NOESY (41) (with a mixing time of 80 ms), and 3D
1H–15N-HSQC-NOESY (41) (with a mixing time of 100 ms)
spectra collected at 700 MHz.
From the analysis of the 3D 15N-edited and 13C-edited
NOESY-HSQC spectra and 2D NOESY spectrum, NOE cross-
peaks were assigned and transformed into unique upper distance
limits by using the program CALIBA (44). More specifically, for
the N-terminal domain of N60D CaM, 2,360 NOE cross-peaks
were assigned and transformed into 2,020 unique upper distance
limits, of which 1,495 were found to be meaningful. For the
C-terminal domain, 1,895 assigned NOEs were transformed into
1,606 unique upper distance limits and 1,225 were found to be
meaningful.
The solution structure of the two domains was calculated with
Fig. 1. Relative orientation of the N-terminal and C-terminal domains in
CaM as early observed by x-ray in the absence of target peptides (A; extended
conformation) and as observed in the presence of target peptides (B; closed
conformation). Labels N4 and C1 indicate the fourth helix of the N-terminal
domain and the first helix of the C-terminal domain, respectively.
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the simulated annealing program DYANA (45) and PARAMAG-
NETIC DYANA (46).
Paramagnetism-Based Constraints. In paramagnetic metal-
loproteins the metal magnetic susceptibility tensor, para, is
usually anisotropic, owing to orbital contributions to the electron
magnetic moment. In solution, this anisotropy produces pcs of
the nuclei that are dipole–dipole coupled to the paramagnetic
metal ion as well as rdc attributable to partial self-orientation
(47–49). The pertinent equations are published as Supporting
Text on the PNAS web site.
Results and Discussion
15N,13C-enriched vertebrate N60D (Ca2)N(Ca2)CCaM was sub-
jected to the standard set of 2D and 3D experiments to assign
backbone and side chains, and to obtain NOE. The relevant data
are summarized in Table 1 and in Tables 3 and 4, which are
published as supporting information on the PNAS web site. The
structures obtained for the two domains are in good agreement
with the latest solution structure refined with the help of rdc (30)
resulting from orienting media (Bax structure). N60D
(CaLn)N(Ca2)CCaM derivatives with Ln  Tm or Tb were
prepared, and an extensive assignment of both N-terminal and
C-terminal peptide NH nuclei was performed by using a semi-
automated procedure previously described (50, 51). The pcs and
rdc values are summarized in Table 1 and in Tables 5 and 6, which
are published as supporting information on the PNAS web site.
Both pcs and rdc values of the C-terminal domain are rather
small. However, they have been measured with good precision,
the estimated uncertainty being 0.05 ppm and 0.3 Hz,
respectively.
Orientations and Anisotropies of the Magnetic Susceptibility Tensors.
The pcs values relative to the N-terminal domain were used
together with the N-terminal atom coordinates from either the
present or the Bax structure (30) to obtain the -tensor anisotro-
pies and principal axes of both the Tb3 and the Tm3 derivatives
according to a well established procedure (50, 52, 53). The
best-fit values are reported in Fig. 2, where the satisfactory
agreement between calculated and observed pcs is also shown
(the correlation coefficient for Tb3 and Tm3 pcs being 0.995
and 0.987, respectively). Such good agreement can be seen as a
validation of the available structures. pcs values were then
provided as additional constraints to the program PARAMAG-
NETIC DYANA (46) together with the obtained magnetic suscep-
tibility anisotropy values. The resulting family of solution struc-
tures of the N-terminal domain of CaM containing the N60D
mutation is deposited in the Protein Data Bank (PDB ID code
1SW3).
These magnetic susceptibility anisotropy tensors determine
the frame to which the positions of the C-terminal domain are
referred. Such positions are referred to as conformations of CaM,
where the N-terminal domain is fixed and the C-terminal domain
is not. The very same N-terminal tensor contributes to induce a
partial orientation of the N-terminal domain in a magnetic field
and tends to induce an orientation also on the C-terminal
domain. Therefore, it is possible to extract information on the
relative orientation of the C-terminal and N-terminal domains.
Testing Single and Uniformly Distributed Conformations. Simple
minimization programs were constructed and used to search the
conformational space of CaM. One of these programs allows
movements of the C-terminal domain, assumed rigid (Bax
structure), relative to the N-terminal domain, also assumed rigid,
through a completely flexible linker of residues 78–81 (16, 17,
23, 25). For any given conformation of the C-terminal domain,
the pcs and rdc values are calculated. This program was first used
to check two extreme situations: (i) fixed single conformations,
such as those observed in the solid state, i.e., the extended and
the closed forms (the latter both with and without bound target
peptide or peptides); (ii) a uniform distribution of sterically
allowed conformations.
(i) A large number of starting conformations was generated
and used in the minimization program. In all cases, the overall
agreement was poor. In particular, for the conformations ob-
served in the solid state a poor agreement was found for both pcs
and rdc, either together or separately. The pcs and particularly
the rdc calculated from the x-ray conformations were much
larger in absolute value than the observed ones. As expected,
there is not a single CaM conformation in solution.
(ii) At the other extreme, a uniform distribution of all
sterically allowed conformations yields average pcs values that
are in reasonable agreement with the experimental ones, but
average rdc values that are in disagreement with the experimen-
tal ones and show two to six times smaller spreading of values.
From the latter observation we conclude that the conformational
space sampled by CaM may be ample, but the distribution must
be nonuniform. In particular, within all possible conformations,
there must be some with less favorable orientations of the
C-terminal domain (note that, as usual in this field, the term
orientation is not related to the position in the reference system).
The fact that not all orientations are sampled equally is an
unexpected finding, whose implications will be further analyzed
below.
Analysis of the C-Terminal rdc. The values and the spreading of the
rdc values for the two metal derivatives may contain information
on the type of rotational average experienced by the C-terminal
NH vectors. Before turning to a deeper analysis of these values,
we need to assess the intrinsic quality of the two sets of
experimental rdc. Any set of meaningful rdc is always describable
by a single orientation tensor, independently of the fact that they
originate from a weighted average of a number of conforma-
tions. The latter tensor can be obtained by a simple fit of the
Table 1. Experimental constraints collected for the N- and
C-terminal domains of CaM
No. of constraints
N-terminal domain C-terminal domain
Meaningful NOEs 1,495 1,225
 dihedral angles 50 43
 dihedral angles 50 43
pcs (Tb3 and Tm3) 125 165
rdc (Tb3 and Tm3) — 67
Fig. 2. Calculated vs. observed values of pcs of N-terminal nuclei for the
terbium(III) (F) and thulium(III) () derivatives. The directions of the  tensor
axes are indicated, and the magnetic susceptibility anisotropies are reported.






tensor parameters to the experimental rdc and to the existing
C-terminal Bax structure, using the FANTAORIENT program
(48, 52). The results of the fit are shown in Fig. 3. It is apparent
that a satisfactory agreement is obtained. The tensor parameter
values are much smaller than those obtained from the analysis
of the pcs of the N-terminal domain NH nuclei. This reduction
is, of course, a consequence of extensive orientation averaging.
The good agreement is a proof only of the reliability of the two
rdc sets.
It is instructive to back-calculate the rdc from the full suscep-
tibility anisotropy tensors of the two metals (case A) and from
the tensors obtained above from FANTAORIENT (case B). Fig. 4A
shows the calculated distribution of the rdc values for case A. As
expected, the spreading is somewhat larger for Tb3 than for
Tm3, because of the larger anisotropy of the former ion. Fig. 4B
shows the distribution of the rdc calculated for case B. For
comparison purposes, Fig. 4C shows the calculated distribution
of rdc values when averaged over all conformations except those
in steric clash with the N-terminal domain. These distributions
are much narrower than in case B, indicating that in the latter
there must be less favorable conformations besides those pro-
hibited by steric clashes.
It is well known that the effect of fitting to a rigid structure the
rdc arising from motional averaging is that of obtaining a
motionally averaged alignment tensor (54, 55). In this case, a
generalized order parameter (47, 56–58) can be defined quali-
tatively as the ratio of the spreading between the observed rdc
distribution (Fig. 4B) and the rdc distribution calculated in the
assumption of no motion (Fig. 4A). Such parameter is equal to
0.05 and 0.15 for Tb and Tm rdc values, respectively. Different
order parameters for the different orienting metal ions indicate
that the C-terminal motion causes different motional averaging
because of the different directions of the principal para axes of
the two metals (Fig. 2). This observation is further evidence that
not all sterically allowed conformations are equally probable.
Search for the Least-Favored Orientations by Using C-Terminal rdc. It
is known that any set of meaningful rdc values can be reproduced
by a given magnetic anisotropy tensor and a weighted average of
three orientations. We grid-generated all C-terminal domain
orientations and, for each one, we searched for two additional
orientations (described by the Euler angles) which, combined
with the given one, gave the best agreement with the experi-
mental rdc data. In some cases, the sum of the squared residuals
coincided with that from the fits reported in Fig. 3, i.e., the lowest
possible value; in some other cases it did not. Details of the
calculation can be found in the supporting text. Such analysis
indicates that, even if all orientations could be sampled by the
C-terminal domain, there are regions in the orientational space
less favored than others, and these regions can be identified. Now,
we face the task of translating this information in Euler angle
space into information on disfavored conformations in real
Euclidean space.
Exploring the Conformational Space with C-Terminal pcs. We have
mentioned that pcs calculated in either the extended or the
closed conformations are not in agreement with the observed
values. We then tried a six-parameter fit (three Euler angles and
three translational parameters) to look for a single conformation
providing a good agreement between calculated and observed
values of pcs of both Tb(III) and Tm(III) simultaneously. A good
fit was actually found corresponding to a conformation charac-
terized by a tilt of the first helix of the C-terminal domain of
34°, with respect to the extended form, in the direction of the
second metal binding site in the N-terminal domain. Such
conformation has no physical meaning, as proved by the fact that
the corresponding rdc are in strong disagreement with the
observed values, but could be seen as a sort of ‘‘average’’
conformation.
If a conformation is chosen with the first helix of the C-
terminal domain tilted by a large angle with respect to the
extended form, as happens in the closed form where the tilt is
90°, a good fit is obtained for the pcs data only by considering
other additional conformations with the interdomain helix again
largely tilted, but in different directions with respect to the first
one. This means that either the closed form is unfavored in
Fig. 3. Calculated vs. observed values of rdc of C-terminal HN for the
terbium(III) (F) and thulium(III) () derivatives. Each set of data was fit
separately by using FANTAORIENT.
Fig. 4. Distribution of the rdc values calculated for all conformations by
using the Bax structure and the magnetic susceptibility anisotropy values
obtained from the experimental rdc of the N-terminal domain (A), from the
experimental rdc of the C-terminal domain (B), and from the average rdc of
the C-terminal domain obtained from sterically allowed uniformly sampled
conformations (C).
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solution, or more than one widely different ‘‘closed’’ form should
be present.
Minimal Sets of Conformations That Agree with Both C-Terminal rdc
and pcs. pcs and rdc data were then fit simultaneously to search
for the conformations providing the lowest value for the target
function, keeping in mind that the lowest possible value for the
target function is set by the sum of the target functions obtained
from the fit performed on pcs (see Exploring the Conformational
Space with C-Terminal pcs) and rdc (Fig. 3) (see Analysis of the
C-Terminal rdc and Search for the Least-Favored Orientations by
Using C-Terminal rdc) separately. The C- and N-terminal do-
mains were held together by a completely flexible linker of
residues 78–81 (16, 17, 23, 25) (such a linker was subsequently
also extended to the range from residue 75 to residue 81, without
significant deviations in the resulting features described below).
The minimization program was then allowed to sample triplets of
conformations with adjustable weights. The ‘‘successful’’ best-fit
triplets provided target functions coincident with the lowest
possible value defined above. We found a large ‘‘density’’ of such
solutions for which the three conformations reside in an elliptical
cone, whose axis is tilted by 30° on the direction of the second
metal binding site of the N-terminal domain (Fig. 5). The major
axis of the ellipsis is roughly parallel to the direction of the
-sheet located on the N-terminal domain. The fit also indicated
that the C-terminal domain rotates about the axis defined by the
C-terminal side of the interdomain helix. The amplitude of the
semiangle of the cone ranges from 50° to 80°. Another set of
calculations was performed allowing four conformations to be
sampled. Often one of the four was with low weight, or the four
were in the same region of space occupied by the conformation
triplets.
To better visualize the results, we also restricted the Euler
angles to assume only those values that provide orientations of
the first helix of the C-terminal domain (see Fig. 1) within a fixed
angle with respect to the orientation of the same helix in the
extended form. This helix was thus restrained to move within a
cone with fixed semiangle, and with symmetry axis along the
direction of the helix in the extended form. The semiangle was
set to increasing values from 10° in steps of 10°. We find that only
a semiangle 40° provides a good fit. This result is due to the
contribution by the rdc to the target function, as a good fit of pcs
data could be obtained already for angles 10°. Another set of
calculations was then performed, allowing four conformations to
be sampled. Again, a semiangle of at least 40° was needed to
provide a good fit. Such a model compares with that proposed
by Baber at al. (17), according to which the rigid linking
C-terminal helix is wobbling within a cone having a maximum
semiangle of 54° with respect to the N-terminal helix.
The first helix of the C-terminal domain was then restrained
to move within a cone with semiangle again variable in steps of
10°, but with the axis of the cone tilted with respect to the
orientation of the same helix in the extended form. A grid search
of solutions comprising three conformations was thus performed
for different orientations and amplitudes of the cone. The results
of the calculations show that there are indeed cones different
from that depicted in Fig. 5, with semiangle larger than 40°,
where it is possible to place three conformations that agree with
the experimental data. In contrast, conformations inside cones
with small semiangles are allowed only for the C-terminal
domain bent in the same direction as that of the closed forms.
We also tested the possibility that the extended form or one of
the closed forms could be present among the conformations.
This testing was done by searching for additional conformations
that, combined with the given one, gave the best agreement with
the experimental data. The result was that two additional
conformations did not provide a good agreement in either case.
Again, this result supports the idea that neither the extended
forms nor the closed forms are particularly favored in solution.
As expected, however, in both cases three additional conforma-
tions with similar weights provide a good fit.
Summary Considerations. The present research provides a further
characterization of the conformational space sampled by domain
reorientation of CaM by using pcs and rdc data.
The first conclusion to be drawn is that the available confor-
mation space is quite ample and spans beyond the cone sug-
gested by relaxation data (17). This conclusion is not in contra-
diction with the previous findings, as the analysis was limited to
motions in the nano- to picosecond scale, whereas pcs and rdc
are averaged by motions spanning a time scale that extends down
to milliseconds. Apparently, slower motions than those affecting
relaxation measurements may contribute to the sampling of
conformational space in CaM.
The second finding is that C-terminal rdc clearly arise from
averaging among very diverse orientations. Therefore, pendu-
lum-like motions, no matter how ample, that do not imply also
a rotation of the C-terminal domain about the axis of its first
helix, are not sufficient in averaging the rdc down to the small
values observed.
However, not all C-terminal orientations are equally probable
(because the rdc would average zero), and exclusion of only those
conformations in steric clash with the N-terminal domain is not
enough to account for the magnitude of the observed rdc.
Electrostatic repulsion between the negatively charged domains
may contribute to the different probability of sterically accessible
conformations.
pcs, taken alone, are seemingly less informative. It is easy to
find two or more conformations, anywhere in the available
conformational space, that agree with the experimental data,
and even a single conformation is only in slightly worse agree-
ment. However, there is information in this finding. The single
conformation in reasonable agreement with the pcs is not far
from the extended conformation (but distinct from it) and very
far from the closed conformations (it is actually slightly tilted on
the opposite side). As pcs depend on the reciprocal third power
of the metal-nucleus distance, this finding by itself indicates that
on average all nuclei of the C-terminal domain are rather far
from the metal in the N-terminal domain. This in turn implies
that, if a closed conformation is populated in solution, there must
Fig. 5. Cone containing the three conformations of the C-terminal domain
(only the first two helices are shown), which provide pcs and rdc with an
average in good fit with the experimental data.






be at least another similarly ‘‘closed’’ conformation on another
side to compensate for the effect of the first.
Taken together, pcs and rdc indicate that, if motions within a
cone are considered, with the exception of a few specific
orientations of the axis of the cone in the direction of the closed
forms, in all other orientations the cone semiangle must be at
least 40° or wider. In light of the findings from relaxation data
(17), we should exclude those few orientations with a too narrow
cone, although they are consistent with the present data.
In conclusion, we point out that the applied procedure is of
general application, as paramagnetic line broadenings decay
with 1r6 (r being the metal-nucleus distance), pcs decay with
1r3 and rdc do not decay at all with distance. Therefore, no
matter how strongly paramagnetic the metal center is, there will
always be plenty of pcs and rdc to be detected outside the region
of excessive broadening. For broadened lines, pcs can be mea-
sured more accurately than rdc. Therefore, if the metal sits in
one domain, large and meaningful pcs can still be measured for
that domain (and used to determine the tensor) while small but
meaningful pcs and rdc can be measured for the other domain
(and used to sample the conformational space).
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STRUCTURAL CHARACTERIZATION OF THE  













5.1  Target Binding Versatility of  Calmodulin 
 
The major conformational change induced by the binding of Ca2+ ion to 
Calmodulin consists in the alteration of the relative orientation of the helices in each 
lobe. This rearrangement of the helices leads to the exposure of several hydrophobic 
residues to the solvent on the surface of each lobe, which are responsible for targets 
binding. 
Biophysical and structural characterization of complexes between CaM and synthetic 
peptides indicated that the ternary complexes have a more compact shape than   
Ca2+-CaM by itself and revealed different ways of binding. On one hand CaM can 
bind target peptides forming a collapsed ellipsoid complex, where both N- and C- 
terminus domain are involved in the binding, as was observed in the structure of 
CaM-peptide complexes from skeletal Myosin light chain Kinase (fig. 5.1a).  
On the other hand the NMR structure of the C20W peptide, representing the CaM-
binding domain of the Ca2+ pump, showed that the peptide is bound only to the C-
terminal domain and that the complex does not collapse into an ellipsoid shaped 
form, but remains in an extended conformation [1] (fig. 5.1b). In both cases, 
conformational rearrangements of the interdomain linker allow CaM to bind its target 















Fig. 5.1 a) Ribbon representation of the Ca4CaM (red) complexed with Rabbit 
Skeletal Myosin Light Chain Kinase (blue) in which CaM adopt a collapsed ellipsoid 
shape (PDB ID code 2BBM). b) Ca4CaM complexed  with the CaM-binding domain 
of the Ca2+ pump, in which C20W peptide (green) is bound only to the C-terminal 
domain of CaM (PDB ID code 1CFF). 
 
 
Analysis of CaM binding peptides revealed that they share no sequence 
homology, but they all have the potential to fold into a basic, amphiphilic α-helix. 
They usually display large hydrophobic residues in conserved positions and show an 
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α-helical conformation. The binding of CaM-binding peptides is largely driven by 
hydrophobic interactions between hydrophobic anchor residues of the peptide with 
the hydrophobic surface cavities of CaM. 
Typically, CaM contains an abnormally high amount of methionine residues 
(9 Met out of a total of 148 amino acid residues), and 8 of the 9 Met residues are 
found in the hydrophobic surfaces of the Ca2+-CaM, with 4 Met residues in each 





Fig. 5.2  Sequence of Calmodulin. The Met (M) residues are highlighted. 
 
The four Met residues in each domain are located at the entrance of the 
hydrophobic-pocket made up of aromatic (Phe) and branched aliphatic (Ile, Leu, and 
Val) amino acid residues as well as short Ala residues. In fact, Met residues 
contribute to about 46% of the total exposed hydrophobic surface area of the 











Fig. 5.3  a) Ribbon representation of Ca4CaM complexed with Rabbit Skeletal 
Myosin Light Chain Kinase (2BBM). The methionines positioned in the entrance of 
hydrophobic-pocket are showed with their molecular surface, b) the methionine 
residue. 
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A surface rich in Met residues was proposed to allow CaM to bind many 
targets in a sequence-independent manner [3]. The existence of a sulphur atom in the 
unbranched side chain entails Met with unique flexibility and high polarizability.     
In fact  the absence of branching permits methionine to assume many different 
shapes, thereby enabling this side chain to adopt many different conformations and 
so adapt to different hydrophobic surfaces (fig. 5.3 b). 
In addition, high polarizability of the surfaces will not only allow the protein to 
interact with its targets via London dispersion forces but also stabilizes the large 
solvent-exposed hydrophobic surfaces in the absence of targets. 
The majority of CaM binding motifs in proteins, which bind it in the 
canonical Ca2+-dependent way, are un-structured in the absence of CaM, and become 
α-helical upon binding to it. The helix is amphipathic and its hydrophobic side 
interacts with hydrophobic pockets of CaM, whereas the hydrophilic face, containing 
four or more basic residues, interacts electrostatically with the acidic residues in 
CaM[4].  
Recently, we have undertaken the characterization of the interaction in solution 
between human CaM and a novel target protein, α-Synuclein, which has unusual 




5.2 Alpha-Synuclein and Parkinson’s Disease 
 
Parkinson’s disease (PD), characterized by resting tremor, slowness of initial 
movement, rigidity, and general postural instability, is one of the most prevailing 
neurodegenerative disorders among elderly population. PD is characterized by the 
loss of dopaminergic neurons from the substantia nigra and the formation of fibrillar 
intraneuronal inclusions. 
The importance of α-synuclein (AS) in the pathogenesis of PD is supported 
by a number of recent observations. Perhaps most suggestive are reports of two 
transgenic animal models for PD produced by introducing the gene for AS into mice 
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and into flies [5,6]. The resultant animals exhibit an age-dependent motor 
dysfunction, the appearance of neuronal AS deposits resembling Lewy bodies (LB), 
and a loss of dopaminergic neurons. This evidence follows on the heels of earlier 
work demonstrating that AS is the primary protein component of the LB deposits that 
are a diagnostic hallmark of PD [7], and  that mutations associated with autosomal 
dominant early onset PD trace to the gene encoding AS [6,8].  
Lewy bodies and dementia with Lewy bodies (DLB), constitute the second 
most common nerve cell pathology, after the neurofibrillary lesions of Alzheimer’s 
disease. Apart from prevalent conditions such as PD and  DLB, lately, AS pathology 
is reported to be associated with a number of neurodegenerative diseases. These 
include Lewy body variant of Alzheimer’s disease (LBVAD), as well as rarer 
conditions including multiple systems atrophy (MSA), and neurodegeneration with 
brain iron accumulation type-1 (NBIA-1). Common in these diseases, sometimes 
referred to as α-synucleinopathies, are microscopic proteinaceous insoluble 












Fig. 5.4 a) Scheme of the formation of amyloid plaques and neurofibrillary tangles 
that are thought to contribute to the degradation of the neurons  in the brain and the 
subsequent symptoms of Parkinson's disease, b) the arrow indicate an α-synuclein 




AS can form ordered fibrillar aggregates that are morphologically similar to 
the amyloid fibrils found in Alzheimer's disease neuritic plaques and in deposits 
associated with other amyloidogenic diseases [9-11]. As in other amyloidogenic 
diseases, it has been suggested that the aggregation of AS into fibril may play a 
causative role in the pathogenesis of PD. Despite the intense interest in AS generated 
by its potential role in PD, the structural properties of this protein have only been 
characterized at low resolution, using circular dichroism (CD) or other optical 
techniques. The reason for this is that AS does not appear to possess an intrinsic 
well-defined native structure [12], making it a member of a class of proteins referred 




5.3 Alpha-Synuclein: an Intrinsically Unstructured Protein 
 
AS is a highly conserved presynaptic protein in vertebrates and only seven of 





Fig. 5.5  Sequence of Human alpha-synuclein. 
 
AS contains a highly conserved amino-terminal repeat region, a hydrophobic 
central region (residues 61-95) and a less conserved negatively charged carboxy-
terminal region (residues 96-140), rich in Pro and in acidic residues like Glu and 
Asp. The central part of AS (residues 61-95) is highly hydrophobic and is believed to 
be the mainly responsible for self-aggregation. The highly conserved amino-terminal 
of all synucleins is also disordered in solution, but can shift to an α-helical 
conformation that appears to consist of two α-helical regions (1-67) interrupted by a 
short break [14].  The α-helical N-terminal domain has an 11 amino acid repeat with 
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a highly conserved hexamer motif (KTKEGV) that contributes to its structural 
propensity for an amphipathic α-helix.  
NMR spectroscopy studies of AS in solution have shown that its C-terminal 
part remains free and unfolded, and does not associate with vesicles or micelles [15]. 
AS, intrinsically unstructured in its native state, it can bind, however, a number of 
ligands and proteins, which likely alter its native state and lead to adopting a partially 




5.3 Calmodulin interact with Alpha-Synuclein 
 
AS experience dramatic structural alteration upon membrane interaction to 
form 80% of α-helicity from its  natively unfolded  structure [12,17]. Via the 
induction of amphipathic α-helices, AS has been suggested to be  involved in 
membrane biogenesis. Since CaM has been known to recognize its target protein 
through the basic amphipathic α-helix [18-20], the physiological function of AS has 
been examined with respect to its CaM regulation and possible implications in 
cellular messenger system. 
Recently, Martinez and co-workers [21] reported that AS interacts with the 
Ca2+-CaM. Martinez and colleagues found this interaction in a screening test using a 
special form of AS, made by in-vitro protein translation that can be activated by 
light. Incorporating chemically modified lysine residues, this AS reacts to light by 
covalently binding to other proteins, but only if they are in close proximity, because 
the light-activation of the lysines lasts only a few nanoseconds. The authors spiked 
bovine brain extracts with this "smart" AS, irradiated the mixture with light, then 
affinity-purified the AS along with whatever had bound to it. Analysis of the latter 
showed that several proteins had made sufficient contact to be covalently captured, 
but subsequent experiments showed that one, about 17 kDa in size, was particularly 
abundant. After purification this protein was identified as CaM. When the authors 
tried similar experiments in the absence of calcium, they did not detect binding 
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between the two proteins, suggesting that their association is calcium dependent and 
thus may have a physiological role. What this could be is uncertain, but when the 
authors mixed AS, CaM, and calcium in vitro, they found that the formation of AS 
fibrils was accelerated. This led them to speculate that Ca2+-CaM drives the assembly 
of AS-containing multimeric complexes, or perhaps regulates the oligomerization 
status of AS. 
CaM and AS are abundant enough to make this a physiologically relevant 
interaction. Intracellular CaM concentrations have been estimated to be 1–10 mM, 
and CaM is estimated to be 0.1–1% of total protein in neurons [22]. Therefore CaM 
concentrations are high enough to allow for physiologically relevant interactions 
with AS, which shows the similar micromolar concentration range. 
Therefore, we set out to analyze this interaction by NMR and we tackled the 
task of undestanding the nature of the CaM-AS interaction at the molecular level, 
and tried to relate it with its possible physiopathological effects. 
The research are still in progress, however, preliminary results obtained are 
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6.1  Introduction 
 
Parkinson's disease (PD) and other neurological disorders are related to the 
formation in neuronal cells of protein aggregates [1, 2]. In particular, in PD these 
aggregates (Lewy bodies) are constituted by fibrillar structures mainly containing α-
synuclein (AS), a small cytoplasmic protein (15 kDa) that is essentially unfolded in 
its soluble, monomeric state [3, 4] and is abundant in the presynaptic space. AS is 
certainly involved in the dopamine signalling process [1]; however, the detailed 
mode of action of AS is still largely unknown. Silencing or knock-out experiments 
showed that AS is not essential for neuronal cell life, but has a role in modulating the 
dopamine signalling process, which would be impaired in the absence of AS 
especially under conditions of fast repeated signalling [5-7]. There are several ways 
by which this regulatory role can be exerted. Among them, a possible one is by 
regulating the activity of phospholipases [8, 9], possibly related to the recycling of 
presynaptic vesicles. Another possible way is direct binding of AS to presynaptic 
vesicles, which might contribute to regulate membrane plasticity. As a matter of fact, 
it has been shown that AS has a strong affinity for membrane surfaces; AS binds to 
membrane surfaces by adopting a α-helical conformation of its N-terminal domain 
[4, 10-13]. Increasing experimental evidence suggests that even the soluble, 
monomeric form of AS is not completely unstructured in solution [4, 14-17]. Soluble 
and membrane-bound forms of AS are reported to be present in similar amounts in 
vivo [1]. In virtually all the processes in which AS may be involved, calcium ions are 
also involved [18-23]. Interestingly, calcium ions interact with the carboxylate-rich 
C-terminal part of AS and modulate its ligand binding and oligomerization ability 
[24]. The nature and morphology of the initial fibrillar aggregates is also affected by 
the presence of calcium ions [25]. 
To further strengthen the links between calcium and AS function/misfunction, 
it has been shown that monomeric AS interacts strongly with calmodulin (CaM), 
with dissociation constants of the order of 10-100 nM [26, 27]. Whether this 
interaction has any physiological or pathological role is not clear, but its 
understanding may shed new light on the whole field of synucleinopathies. 
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With these premises, we tackled the task of understanding the nature of the 
CaM-AS interaction at the molecular level, and to try to relate it with its possible 
physiopathological effects. The interaction is strong, as previously reported. NMR 
measurements clearly show that the interaction occurs only with the calcium-loaded 
form of CaM, and involves the N-terminal part of AS. The lack of internuclear 
NOEs, between the C-terminal and N-terminal domains of CaM, evidences that the 
adduct is highly fluxional, possibly involving fast opening and closing of the two 
CaM domains. The large part of AS is not involved in the interaction with CaM and  
is still largely – but not completely – unstructured. Calcium-loaded CaM is found to 
slow down fibril formation by at least a factor two, while apo-CaM has no effect. 
The fibrils that form in the presence of CaM do not involve co-precipitation of 





6.2.1 Protein Preparation 
 
15N and 13C labeled wild type (WT) CaM and N60D CaM were prepared and 
purified as previously reported [28, 29]. Plasmid pDEST-17 (Invitrogen) able to 
express his-tagged AS was transformed into BL-21-AI E. coli strain.  A primary 
culture was from a single bacterial colony diluted up to 1 L either with the LB media 
or M9 minimal media supplemented with the appropriate isotopically labeled 
nitrogen (1.2 g 15NH4Cl/L) and carbon sources (3 g 13C-glucose/L), and grown in a 
shaker. AS expression was induced at mid-log phase stage with 0.2% L-arabinose. 
The bacterial cells were harvested at 7 hrs of post-arabinose induction, centrifuged 
and resuspended in 15 mL of ice-chilled lysis buffer (0.05 M Tris, 0.5 M NaCl, 0.01 
M Imidazole, pH 7.2) containing 0.05 mg/mL lysozyme and 1 mM PMSF and 
incubated on ice for 30 min to achieve the maximum activity of lysozyme. A lysate 
obtained by sonication was boiled for 15 min to inactivate all the bacterial proteases 
co-expressed with his-tagged AS and centrifuged. The supernatant containing his-
 70
tagged AS was loaded on to a hi-trap chelating column charged with NiSO4 solution. 
Other proteins were removed from the column by passing 25 mL of lysis buffer 
followed by 25 mL of washing buffer containing 0.02 M imidazole. The his-tagged 
AS was eluted with 15 mL of elution buffer, containing 0.3 M imidazole. The eluate 
fractions were pooled and the buffer of eluates was exchanged with the factor Xa 
protease buffer (0.02 M Tris, 0.1 M NaCl, 0.002 M CaCl2, pH 8.0). His tag was 
cleaved off from the native AS by incubating the uncut protein with the factor Xa 
protease enzyme for 5 hrs at 37°C. Finally, the native un-tagged AS was purified by 
size exclusion chromatography using Superdex 75 column (Amersham pharmacia). 




6.2.2 NMR Sample Preparation and Measurements 
 
NMR samples of CaM were prepared by buffer exchange by Centricon 
(MILLIPORE)  ultrafiltration with membrane cutoff of 10000 Da, as previously 
reported [28]. NMR samples conditions were 200 mM KCl, 20 mM MES and 5% of 
D2O. The pH was adjusted to 6.8 using 0.01 M NaOH or HCl solutions. Final 
concentrations of single and doubly-labelled samples were around 0.6 mM. Apo WT 
CaM and N60D CaM samples were titrated up to 4 equivalent of Ca(II) by addition 
of CaCl2. Tb3+-substituted N60D CaM samples, with Tb3+ replacing the Ca2+ ion in 
the second EF site of the N terminal domain, were prepared by titration up to a 
Tb3+:Ca2+ ratio of 0.9:1 [29] to avoid occupancy of other sites. 
Labeled WT CaM and N60D CaM were slowly titrated with unlabeled human 
AS up to final ratios of 1:1 (CaM-AS). No precipitation was observed under these 
conditions. The titration progress was followed by 2D 1H-15N HSQC spectra at 700 
MHz and 298K. Titration of labeled human AS with unlabelled human CaM was 
performed under the same conditions. 
The NMR spectra were acquired on Bruker AVANCE 600 and 700 
spectrometers. Both spectrometers were equipped by a triple resonance (TXI) 5 mm 
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probe with a z-axis pulse field gradient. All spectra were taken at 298 K.  The water 
signal was suppressed using presaturation during the relaxation delay and mixing 
time or by using the WATERGATE [30] method. 
In order to obtain the pseudocontact shifts (PCS), 298 K 1H-15N HSQC spectra 
of (Ca2)N(Ca2)CCaM-AS and of (CaTb)N(Ca2)CCaM-AS were recorded. 256 
increments each with 1024 complex data points and 48 transients were collected. 
PCS were calculated as the difference in chemical shift between corresponding 
nuclei in the paramagnetic and diamagnetic samples. One bond 1H-15N coupling 





6.2.3 Resonance Assignments 
 
Spin system identification of CaM when interacting with AS was made for a 
substantial number of amino acids trough the analysis of 2D 1H-15N HSQC. The 
analysis of a 3D 15N-NOESY-HSQC allowed for the assignments of few missing 
residues. A total of 135 out of 148 HN an N backbone peaks was assigned. 
Assignment of side chains protons was obtained through the parallel analysis of 15N 
and 13C NOESY HSQC spectra. 
For the AS when interacting with CaM, sequential backbone connectivities 




6.2.4 Structure Calculation 
 
The program DYANA [33] employing torsion angle dynamics (TAD) 
combined with a simulated annealing algorithm was used to calculate a series of 200 
structures in 10,000 annealing steps starting from randomly generated conformers. 
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The metal ions were introduced by a linker made of pseudoatoms to the C-terminal 
and were imposed to be between 2.0 and 2.8 Å from the donor atoms of the four 
calcium binding loops [34].  
The 20 structures with the lowest target function were included in the final set 
for restrained energy minimization (REM) performed with the Sander module of 
Amber [35] by applying the NOE and dihedral angle restraints. The RMSD values 
from the mean for the backbone atoms and for all heavy atoms were determined. The 
program PROCHECK [36] was subsequently used for secondary structure analysis 




6.2.5  AS Fibril Formation 
 
The effect of CaM on fibril forming propensity of AS was monitored by turbidity, 
and thioT-binding assays. 500 µl of freshly prepared AS (250 µM) was incubated 
with or without 1:1 amounts of CaM or apo-CaM at 37 °C in glass vials under 
constant stirring with micro stir bars. 250 µM of CaM without AS was also incubated 
under same experimental conditions. The buffer condition used for the incubation 
was as follows: 20 mM Na-MES, 0.1 M NaCl, pH 7.0.  
Aliquots (1.5 µl) of AS were taken from each incubation vial at different time 
intervals and added to 2 mL of 5 µM thioT in 20 mM Na-MES, pH 7.0, according to 
published procedures [37]. Fluorescence measurements were carried out on a Cary 
Eclipse spectrofluorimeter using 3.5 mL quartz cuvette (Hellma) with a 1 cm light-
path. Fluorescence intensity of thioT was measured at 480 nm, using excitation at 
446 nm, an integration time of 0.1 second, and both excitation and emission 
bandwidths of 10 nm. 
Aliquots (9 µl) of AS from the incubation vials were added to 441 µl of the 
same buffer used for incubation. The absorbance at 360 nm, an indicatore of turbidity 
[37], was recorded using a 1 cm path-length quartz cuvette (Hellma) in a Cary 50 




6.3.1  Binding Experiments and Structure Determination 
 
The binding of human CaM to human AS was tested by following the changes in the 
1H-15N HSQC spectrum of 15N-labelled CaM upon addition of an increasing amount 
of unlabelled AS. A number of CaM HSQC signals were affected by the interaction. 
Along the titration, many signals shifted and some disappeared (fig. 6.1) while the 
average signal linewidth increased slightly. Further additions of AS did not cause 


















Fig. 6.1 Superposition of 1H-15N HSQC of  Human CaM (blue) and 1H-15N HSQC of 
Human CaM upon complexation with AS (red). Assigned peaks are labeled with 
their corresponding residue number. The location in the sequence of the residues that 
shift (green) or disappear (yellow) in the CaM-AS adduct is shown. 
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 The affected signals could be already identified from pre-existing CaM 
assignment [29] under similar conditions. The magnitude of the shifts is on average 
sensibly smaller than observed in other cases [38-40]; nevertheless, they clearly point 
to an interaction of canonical type, in the sense that it extends to both CaM domains 
as well as to the interdomain linker, similarly to what observed for several other 
adducts of CaM with target peptides [39, 40] in which CaM wraps around its target 












Fig. 6.2 Plot of the change in chemical shift observed for the Human CaM HN and N 
backbone atoms in the 1:1 15N CaM-AS complex.  Shifts are reported as a weighted 
average using the formula: ( ) ( )( )[ ] 5.02HNN2H γγδδδ ×∆+∆=∆  
 
 
 Shift changes during titration sets an upper limit for the dissociation constant 
around 10-5 M. Such experiments were performed with both the recombinant WT 
protein and the protein engineered with a mutation at one of the calcium binding site 
(N60D) to exploit the possibility provided by paramagnetism, and showed identical 
behaviour. All experiments described hereafter were then performed with the mutant 
protein. Analogous titration experiments performed with calcium-free CaM did not 
show any appreciable alteration of the HSQC spectrum upon addition of AS, 
pointing to a calcium-dependent binding mode. 
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Difference CD spectra were recorded by titrating CaM into AS and viceversa, 
at micromolar concentrations. The binding was essentially stoichiometric even at 
these much lower concentrations with respect to those of the NMR experiments, 
indicating a dissociation constant sizably below micromolar, consistent with the 10-
100 nanomolar values previously reported [26, 27]. 
 A 1:1 CaM-AS sample containing 13C-15N-doubly labelled CaM and 
unlabelled AS was thus prepared under the same solution conditions as the 1H-15N 
HSQC titration described above, and subjected to a complete set of 2D and 3D NMR 
experiments for structure determination. The acquisition parameters  and the 




 Dimension of acquired data Spectral width 
Experiments (Nucleus) (Hz) 
 t1 t2 t3 F1 F2 F3 
1H-15N HSQC 256 (15N) 2048 (1H) - 2909 10000 - 
1H-13C HSQC 256 (13C) 2048 (1H) - 26455 9615 - 
[1H-1H] NOESY 1024 (1H) 4096 (1H) - 10000 10000 - 
CBCA(CO)NH 96 (13C) 48 (15N) 1024 (1H) 13888 2403 9765 
CBCANH 96 (13C) 48 (15N) 1024 (1H) 13888 2403 9765 
1H-13C-HSQC-NOESY 240 (1H) 60 (13C) 1024 (1H) 9765 13158 9765 
1H-15N-HSQC-NOESY 340 (1H) 48 (15N) 1024 (1H) 9765 2415 9765 
1H-15N HSQC (PCS) 256 (15N) 2048 (1H) - 2484 11261 - 
1H-15N HSQC (JNH-split) 256 (15N) 2048 (1H) - 2484 11261 - 
Isotope Filtered [1H-1H] 
NOESY 
1024 (1H) 4096 (1H) - 10000 10000 - 
 




Distance Restraints N terminal C terminal 
Total 1686 1285 
Intraresidue 204 185 
Sequential        (i,i+1) 554 408 
Medium range  from 
(i,i+2) to (i,i+5) 
619 444 
Long range  from (i,i+5) 309 248 
M2+/3+ Restraints   
Total 12 12 
I site 6 0 
II site 6 0 
III site 0 6 
IV site 0 6 
Dihedral Angles   
Total 79 77 
φ 41 39 
ψ 38 38 
STRUCTURAL STATISTICS   
Most favoured region 81.2% 83.9% 
Additional allowed region 14.5% 12.9% 
Generously allowed region 4.3% 3.2% 























Table 6.2  Type and Number of restraints used in the Dyana Calculation and Structural Statistics  
 
 
These data, together with the full table of upper distance limits, are submitted 
to BMRB. The structure calculations, performed with the program DYANA and 
subsequent restrained energy minimization (REM), yielded well resolved structure 
families for both CaM domains (Table 6.2). The two structure families, shown in 
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figure 6.3 and 6.4, have been deposited in PDB (ID code 1YOQ, 1YOS) together 

























Fig. 6.2  NMR structure families (1YOQ) and minimized average structures (1YOR) 
of the N terminal, NMR structure families (1YOS) and minimized average structures 
(1YOT) of the C terminal of the two domains of Human CaM complexed with 
Human AS. 
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No NOEs could be unambiguously assigned to CaM-AS intermolecular 
contacts. Edited experiments either on the CaM or on the AS side also failed to 
reveal intermolecular NOEs. Possibly due to the unfolded nature of AS, the lack of 
intermolecular NOEs, poses the structural characterization of adduct between CaM 
and AS elusive, or it may be indicative of a true fluxional behavior of the complex. 
The lack of intermolecular NOEs poses the problem of correctly placing AS 
within the channel. 13C-15N doubly labelled AS was thus prepared, and the backbone 
signals assigned using again standard 2D and 3D experiments. 
Sidechain signals were also recorded. Very little shifts of either backbone or side 
chain signals were observed upon addition of CaM. However, several signals 
disappeared upon binding to CaM. Careful inspection of the spectra showed that 
these small perturbations tend to cluster in the first third of the AS sequence (fig. 6.6 
and fig. 6.7). The N-terminal domain of AS is reported to be the part of the protein 
with larger helical propensity [4], and therefore to be the most likely region for 














Fig. 6.6  Plot of the change in chemical shift observed for the Human AS HN and N 
backbone atoms in the 1:1 15N AS-CaM complex.  Shifts are reported as a weighted 

























Fig. 6.7  Superposition of 1H-15N HSQC of Human AS (black) and 1H-15N HSQC of 




6.3.2 The Fluxional Nature of the Adduct 
 
The use of paramagnetic metal ions may help elucidating the long range spatial 
relationships and the dynamics in proteins and in protein-protein interactions [17, 34, 
42]. Substitution of a paramagnetic lanthanide ion in one of the calcium binding sites 
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of CaM may provide information on the structure and conformational fluxionality of 
the system [29]. We have therefore prepared a CaM derivative where Tb3+ is 
selectively substituted at the second calcium binding site of the N-terminal domain of 
CaM. Selectivity is achieved by a N60D mutation at the second metal binding loop, 
as previously described [28]. Tb3+ provides large pseudocontact shifts (PCS) in the 
N-terminal domain of the protein and small PCS in the C-terminal domain. The small 
effect on the C-terminal domain is partly due to the much larger distance of the C-
terminal nuclei from the paramagnetic center and partly to the very large fluxionality 
of the C-terminal domain in free calcium CaM in solution [29]. The presence of the 
paramagnetic lanthanide also induces residual dipolar couplings (RDC) that can be 
measured, for instance, in 1H-15N HSQC spectra [43]. RDC do not depend on 
distance, and therefore the spreading of their values should be approximately the 
same in both the N- and C-terminal domains, if there were no relative motion 
between the two. Indeed, in free CaM, due to the very large interdomain motions, the 
RDC spreading in the C-terminal domain was found to be only about 5% that of the 
N-terminal domain [29]. 
PCS and RDC were thus measured from the 1H-15N HSQC spectra of 15N 
labelled Tb-CaM in its adduct with AS, and, conversely, in the 1H-15N HSQC spectra 
of 15N labelled AS in its adduct with Tb-CaM. In order to interpret the results, the 
magnitude and orientation of the Tb-centered magnetic susceptibility tensor have to 
be established. This is accomplished by fitting the large PCS values of the N-
terminal domain of CaM to its energy-minimised average structure, as obtained from 
the present experimental family (fig. 6.2 1YOR). The fit was good, the correlation 
coefficient being 0.988. No sensible improvement was obtained by using the PCS 
themselves in a few structure-refinement cycles using the program 
PARAMAGNETIC DYANA [44]. The tensor parameters (magnitude and 
orientations) are similar, but not identical, to those observed for free Tb-CaM [29], 
consistent with the slight but non negligible structural changes that usually occur 
from the free to the peptide bound state of the protein [45]. Using the magnetic 
susceptibility tensor parameters the spreading of the RDC values for the C-terminal 
domain, assumed rigidly anchored to the N-terminal domain, can be predicted and 
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compared with the experimental one, as well as with that observed in peptide-free 












Fig. 6.8  Predicted (A) and observed (B) spreading of RDC values in the C 
terminal domain of Tb-CaM complexed with Human AS. The observed spreading in 




It is apparent that the spreading is much smaller than predicted (about 15-20%), 
but still sizably larger than that observed in the peptide-free protein (ca. 5%). It can 
be concluded that indeed the CaM-AS adduct is highly fluxional. 
The availability of the tensor parameters allows us also to predict the sign and 
magnitude of the PCS in the region of space around the N-terminal domain, and 
particularly i) in the region occupied by the C-terminal domain and ii) in the regions 
of space on either side of the channel, where the rest of the AS peptide should extend 
outside the binding region. The predicted PCS in the region occupied by the C-
terminal domain are generally small, and span from slightly positive to slightly 
negative (fig. 6.9), the latter being predominant, consistently with the observed PCS 




Residue N (ppm) HN(ppm) Residue N (ppm) HN(ppm) 
L4 0.64 0.73 S101 -0.10 -0.07 
T5 0.97 0.99 A102 -0.28 -0.12 
E6 1.22 1.08 R106 -0.13 -0.08 
E7 1.12 0.99 K115 -0.09 -0.05 
A10 1.04 1.45 E119 -0.12 -0.10 
E11 1.30 1.25 E127 -0.05 -0.05 
E12 1.55 1.54 A128 -0.04 -0.05 
E14 0.65 1.30 I130 -0.04 -0.05 
A15 0.68 1.71 D131 -0.05 -0.06 
L18 0.70 0.83 G132 -0.02 -0.04 
K21 -0.12 -0.12 G134 0.08 -0.07 
G23 0.71 0.66 Q135 -0.03 -0.05 
D24 1.42 1.05 V136 -0.05 -0.07 
N42 -1.03 -0.89 N137 -0.06 -0.10 
E45 -1.39 -1.04 Y138 -0.09 -0.10 
V91 -0.15 -0.11 E140 -0.10 -0.11 
K94 -0.05 -0.11 F141 -0.04 -0.10 
D95 0.01 -0.05 V142 -0.04 -0.14 
G96 0.01 -0.08 Q143 -0.40 -0.35 
N97 -0.03 -0.07 M145 -0.21 -0.13 
G98 0.02 -0.07 T146 -0.92 -0.11 
Y99 -0.05 -0.08 A147 -0.07 -0.11 
I100 -0.09 -0.07 K148 -0.11 -0.23 
 
Table 6.3 PCS values experimentally determined for Tb3+ substituted 15N-















Fig. 6.9 Structural model of the CaM-AS adduct. Green: CaM N-terminal; orange: 
CaM C-terminal; magenta: N-terminal part of AS (residues 10-30), depicted as α-
helical. The C-terminal part extends to the right. The blue dots indicate positive PCS 
regions, the red dots negative PCS regions, and the density of the dots represent the 
expected magnitude of the PCS. The PCS values are calculated from the magnetic 
susceptibility tensor centered on the Tb3+ ion in the second metal binding site of the 
N-teminal domain of CaM. 
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Experimentally derived PCS, although consistent with the structural model of 
CaM in a close conformation, have not been used for refinement of the C-terminal 
domain because of its large relative mobility. Whenever sizable mobility is present, 
the observed PCS are a weighted average of all sampled conformations [43]; 
refinement would imply the presence of a single conformation. 
An interesting finding is that the sign of the PCS is opposite on opposite sides 
of the channel. This feature can be used to discriminate between the two possible 
orientations of the AS chain with respect to the channel. Despite AS is largely 
unstructured, its finite length poses intrinsic limits to the space that can be sampled 
by the C-terminal chain coming out of one of the two sides of the channel. In other 
words, it is expected that the PCS of the C-terminal part be predominantly positive if 
the C-terminal chain comes out on one side of the channel, and predominantly 
negative if it comes out on the other side. The measured 1H and 15N PCS on AS are 
small, and for the 15N nuclei are within the indetermination of the measurements. A 
plot of the 1H PCS as a function of residue number (fig. 6.10), however, shows a 
clear bias towards negative PCS values, especially around residues 70-100, i.e. well 













Fig. 6.10 Plot of PCS observed for the AS HN backbone atoms, for the 1:1 15N 
AS:CaM-Tb loaded complex. 
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This observation shows that the orientation depicted in figure 6.9 is the 
correct one.  Adventitious binding of traces of Tb(III) to AS sites might in principle 
jeopardize the significance of the observed PCS, even if Tb(III) was used in 
substoichiometric amount with respect to CaM to minimize traces of free metal. 
However, metal ions are well known to have preferential binding sites in the 
carboxyl-rich C-terminal end (residues 109-140) of AS [24], and this preference is 
even more marked for lanthanides. Therefore, the clustering of negative PCS values 
in the region 70-100 of AS is unambiguously due to a true effect from the Tb(III) ion 
bound at the N-terminal of CaM. 
In summary, the use of the paramagnetic metal has allowed us to i) verify the 
fluxionality of the adduct and ii) assess the orientation of the AS chain within the 
CaM channel. The question of the orientation is not a trivial one, as both orientations 
have been experimentally observed in other adducts of CaM with target peptides 
[46]. Figure 6.9 collects the structural information obtained in the present work: the 
two CaM domains are well structured; their reciprocal orientation has a higher 
uncertainly, but still allows one to derive a structural model consistent with a closed 
form of CaM; the interacting portion of AS is not known exactly but lies within the 
first 50-60 residues; finally, the orientation of the peptide within the channel is 
determined by the negative sign of most 1H PCS in the C-terminal domain. The 
relative motion of AS with respect to CaM in the adduct could be visualized either as 
a gliding along the two domains or sticking to one of the two when CaM undergoes 
an opening/closing movement. In the latter case, AS would be predominantly bound 
to the C-terminal domain, as PCS and especially RDC would be larger than observed 
if it were bound to the N-terminal domain. The lack of any observed NOEs between 
AS and any CaM domain makes the gliding model preferable with respect to 
predominant binding to the C-terminal domain. 
Another interesting finding is that not all RDC values of AS in the adduct with 
Tb-CaM are negligibly small. The RDC values of AS should be very close to zero if 
the peptide were fully unstructured and able to sample nearly all NH vector 
orientations. Instead, positive and negative values of up to 6-7 Hz in magnitude are 
observed, and they are scattered more or less homogeneously throughout the AS 
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sequence. It is of course impossible to derive any structural model from these data, 
but they clearly indicate that, although lacking any consistent three-dimensional 
organization, the central and C-terminal parts of AS may have a tendency to take up 
some local transient secondary structure. It is possible that this tendency is enhanced 
or at least altered by the entrapment of the N-terminal domain in the CaM channel. In 





6.3.4 Fibril Formation 
 
The tendency of AS to form fibrils was estimated by turbidity measurements and 
thioflavin-T assay as previously reported [37]. AS alone and in the presence of apo-
CaM showed an increase in both turbidity and thioflavin-T fluerescence around 5 hrs 
incubation time, while the onset of both phenomena occurred at times twice as long 
in the 1:1 AS-CaM sample. It can be concluded that CaM, but not apo-CaM, has a 
retarding effect on fibril formation under the present experimental conditions. It was 
also noted that the thioflavin-T response in the presence of CaM was more intense. 
As the thioflavin-T monitors exposed β-sheet structures, this observation suggests 
that the morphology of the resulting fibrillar material may be different. To assess 
whether this material were constituted by CaM-AS adducts instead of AS alone, 
calcium content was monitored both in the fibrils and in the supernatant. Only about 
3% of CaM was found in the fibrils according to their calcium content, suggesting 
that the latter were essentially constituted by AS alone. These data are paralleled by 
UV measurements and gel electrophoresis on the supernatant, which contained 








Whatever the functional significance is of the CaM-AS interaction, and 
whatever can be its role in the pathogenesis of synucleinopaties, the present findings 
add solid knowledge to the mechanistic details of this interaction. Analyzing this 
knowledge in the frame of what is already known about these two proteins may 
actually provide hints and suggestions for future research. Two previous reports have 
shown that CaM interacts with AS both in vitro and in vivo [26, 27]. The binding is 
strong, as confirmed by the present research. CaM is essential for all cells and is 
relatively abundant, with concentrations in the micromolar range [47]. AS is 
localized in the presynaptic space of neurons, and the concentrations of its soluble 
monomeric form in these compartments are also above the micromolar range [48]. 
CaM cycles between its apo form and its calcium-bound form during calcium 
transients, which bring the intracellular calcium concentrations above 1 µM. Calcium 
CaM, when formed, triggers a number of events, depending on the particular state of 
the cell. More than 100 different physiological partners of calcium CaM are known 
[49]. Usually the concentration of calmodulin is sizably higher than the individual 
concentration of its partners, although probably lower than their total concentration 
[47], thereby allowing for multiple events being triggered by a single calcium 
transient. Only the calcium bound form of CaM is able to bind AS. The dissociation 
constant ensures that at the physiological concentrations the adduct would be close to 
100% formed, although competition with stronger binding partners is possible. AS 
could thus be a novel bona-fide CaM partner. As the total concentrations of CaM and 
AS are of the same order of magnitude, from the thermodynamic point of view a 
large fraction of soluble AS in the presynaptic space could be bound by CaM after 
each calcium transient. A crucial point is the frequency of occurrence and duration of 
calcium loaded CaM in the absence of any partner. Measurements performed in 
dopaminergic neurons of the substantia nigra indicate that the basal frequency of 
calcium transients is around 1 Hz and the duration is of the order of tenths of seconds 
[50-52]. CaM responds effectively to this transients [53]. During this time scale the 
CaCaM-AS adduct should form. This event depends on the kon rate constant, which 
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can be estimated from the present data. A few CaM 1H-15N HSQC cross peaks 
disappear during titration of CaM with AS, indicating exchange broadening, while 
several are in fast exchange. From the separation in chemical shift of the latter 
resonances, a reasonable estimate of the adduct lifetime of about 10−2 s is obtained. 
With a dissociation constant of about 10-7 M, and assuming that formation of the 
adduct is a one-step process, the rate constant for the formation of the adduct would 
be 109 M-1s-1. This order of magnitude estimate, although relatively high, is 
reasonable as the kon of proteins of similar size like barnase/barstar was measured to 
be 6×108 M-1s-1 [54]. Such kon and koff values warrant the prompt formation and 
dissociation of the adduct at each calcium transient, i.e. for a significant fraction of 
time. During faster calcium firing events the adduct could remain formed for even 
longer times.  
The lifetimes of CaM adducts with some of its target proteins are similar to 
that of the CaM-AS adduct [55], while many others are somewhat longer, as judged 
from the completely slow exchange observed in NMR experiments [39, 40]. Many of 
its adducts with downstream effector proteins might actually survive throughout 
moderately fast trains of calcium transients, while that with AS might not, except for 
the fastest. Therefore, rather than responding to calcium signals to perform a 
function, AS might actually act as a modulator of CaM operating on its calcium 
form. 
On the opposite side, another implication of AS binding to CaM might be that 
CaM modulates the ability of AS to bind membranes, either of the dopamine-
carrying vesicles or of the presynaptic junction. Binding to CaM essentially shifts the 
equilibrium towards the membrane unbound state of monomeric synuclein [26], 
while low calcium transient frequencies, corresponding to the resting state of the cell, 
would favour binding of AS to membranes. It is interesting that the mode of binding 
to CaM elucidated in the present work implies the N-terminal part of AS, which is 
the part involved in membrane binding, suggesting that modulation occurs through 
direct competition. 
Finally, the retardation of fibril formation by calcium-CaM, but not by apo-
CaM, may have implications for the molecular mechanism of synucleinopaties. Fibril 
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formation, like the formation of any aggregate, either amorphous or crystalline, is a 
complex phenomenon that needs a seeding event. Indeed, ample evidence suggests 
that AS fibrils are thermodynamically much more stable than monomeric AS [17, 
56]. The latter should therefore be regarded as a metastable form, which survives for 
kinetic rather than thermodynamic reasons. If free monomeric AS occasionally 
assumes a "dangerous" β-strand-like conformation of its central part, accidental 
interaction with another AS molecule may trigger the same transition in the latter, 
and act as a seed for β-sheet formation. It is very likely that such transient β-strand-
like conformation in CaM-bound AS is disfavoured. Therefore, in the presence of 
CaM, a lower amount of free AS in solution would be available to seed fibril 
formation. In this respect it should be noticed that, under the conditions of the 
experiments typically used to induce and monitor fibril formation, and also adopted 
here, many such seeds may form at the same time, producing a rather amorphous 
fibrillar material. Interestingly, the fibrils that eventually form in the presence of 
CaM are of better quality, as judged from the thioflavin-T assay, suggesting that the 
number of seeds has been reduced. This in turn is consistent with the idea that the 
protective effect is given by the subtraction of free AS from solution. 
Fibril formation occurs over time scales that are much longer than the lifetime 
of the CaM-AS adduct and longer than the calcium transient intervals. Therefore, one 
might envision the transient binding of free AS to CaM when calcium concentration 
in the presynaptic space increases, as a way the cell adopts to reduce the probability 
that a β-strand-like conformation is adopted by a given AS molecule in the time 
interval between calcium transients when it is free in solution. Calcium transients in 
the presynaptic space are related to neuronal firing [57]; AS is also related to 
neuronal firing either through binding to vesicle membranes, or through regulating 
the synthesis of membrane components, or both; calcium is known to bind to the C-
terminal part of AS and to modulate its tendency to fibrillate (very high, non-
physiological calcium concentrations are needed for this interaction: it is possible 
however that such concentrations are reached locally in some pathologies). Now we 
have shed more light on the relationship that may exist between calcium 
concentration changes and AS through its binding to calcium CaM. This relationship 
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is more subtle than the direct calcium-AS interaction at high calcium concentrations, 
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SPECTROSCOPIC AND POTENTIOMETRIC STUDIES OF 














7.1  Cap43 Protein: a Nickel Carcinogenesis-related Marker 
 
Cancer is a second, leading cause of death in humans worldwide. 
Exposure to a wide variety of natural and man-made substances in the environment 
accounts for at least two-thirds of all the cases of cancer. These environmental 
factors include lifestyle choices like cigarette smoking, excessive alcohol 
consumption, poor diet, lack of exercise, excessive sunlight exposure. Other factors 
include exposure to certain medical drugs, hormones, radiation, viruses, bacteria, and 
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environmental chemicals: solvents, dioxins, polycyclic aromatic hydrocarbons and 
several metal compounds that may be present in the air, water, food, and workplace.  
In 1990, the International Agency for Research on Cancer (IARC) evaluated the 
carcinogenicity of nickel on the basis of well documented studies both in vitro and in 
vivo [1-7].  
All Ni compounds except for metallic Ni were classified as carcinogenic to humans. 
Human exposure to Ni is environmental and occurs primarily via inhalation and 
ingestion [8]. 
Although occupationally exposed nickel mining, smelting and refinery workers have 
an excess incidence of lung and nasal cancer [9], the utilization and disposal of 
nickel-containing products in modern industry lead to environmental pollution by 
both soluble and insoluble forms of Ni, resulting in a serious hazard for not typically 
work-related exposed targets (population). Additionally, combustion of fossil fuel 
contributes significantly to environmental burden, mostly by producing aerosols 
containing soluble Ni [10]. 
All these evidences make it a modern toxic and carcinogenic environmental 
contaminant. 
The understanding of how nickel exerts its toxic and carcinogenic effects at a 
molecular level may be important in risk assessment, as well as in the treatment and 
prevention of occupational diseases. 
The study on molecular level of Ni carcinogenesis has been challenging 
because carcinogenic nickel compounds were weakly mutagenic in most assay 
systems, even though they were able to produce oxidative DNA damage and inhibit 
DNA repair activity [8,11-15]. 
Current studies in the clinical cancer research area focus on either the early detection 
of this disease or on the development of new selective treatment tools. New tumour 
markers can provide aid in cancer early diagnosis and create novel treatment 
opportunities. 
Cap43, also named Ndrg1, following the discovery of its gene NDRG1, is a 
stress responsive protein which shuttles between cytoplasm and nucleus upon certain 
noxious stimulations [16-20]. 
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The Cap43 gene is induced by a rise in free intracellular Ca2+ following nickel 
exposure [16,21]. No other metal compound significantly induced expression of this 
gene, indicating that it is expressed with marked specificity to Ni(II) exposure [22]. 
Exploration of NDRG1 protein expression patterns in various tissues showed that 
Cap43 protein is overexpressed, compared to normal tissues, in a variety of cancers 
including brain, breast, lung, and melanoma cancers [16,22]. Because of its 
differential expression in cancer tissues and the high stability of the protein, Cap43 is 
proposed as a useful new tumor marker. 
This finding makes the Cap43 protein an interesting candidate for studies of 
molecular mechanisms implicated in toxicity and carcinogenicity of nickel 
compounds, because a promising way to unveil these molecular events is to study the 





7.2  Nickel Binding Sites in Cap43 Protein 
 
Recently it has been postulated that Cap43 is as a tumor suppressor gene 
because it causes the reversal of malignant phenotype in colon cancer cells [23]. 
Acute stress, such as heat, and some metals such as cadmium, mercury, lead, zinc 
and Ni(II), induce a specific group of stress proteins referred to as heat-shock 
proteins. The heat-shock proteins contribute to the survival of cells following a 
variety of stresses. Similarly nickel, like other heavy metals, is able to increase the 
levels of metallothionein (MT) and acute phase reactant proteins (APRs), a metal-
binding protein that has also been found to have a protective and detoxification role 
in the cellular response to acute stresses determined by heavy metals.  
These proteins have metal-binding domains that exert a protective effect against the 
cellular toxicity of metal ions. For example, MTs have high affinity for metals due to 
their high cysteine content [24]; purified Limulus C-reactive protein, a member of 
the APR family, has sulphydryl groups that bind strongly to mercury [25], and HSPA 
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from Helicobacter pylori features a series of cysteine and histidine residues, 
resembling anchoring binding site for metal ions [26]. 
For this reason we focused our attention on the ability of nickel(II) to interact with 
Cap43 protein. 
Cap43 has no cysteine or histidine-rich motifs for metal binding, but it possesses a 
mono-histidine fragment composed by 10 amino acids (Thr–Arg–Ser–Arg–Ser–His–
Thr–Ser–Glu–Gly) whose sequence is repeated consecutively three times, suggesting 
a nickel binding motif at the C- terminus (fig. 7.1). It should be mentioned that such 
mono-histidine fragments, e.g. octapeptide repeated regions in prion proteins, play a 
critical role in metal metabolism using sets of His imidazoles as the binding sites for 









Fig. 7.1    Sequence of nickel-specifically induced protein Cap43. The three-time repeated 10-































































































During my PhD course I have analyzed, for Ni(II) binding, the 20-amino acid 
C-terminal sequence of the Cap43 protein -TRSRSHTSEG-TRSRSHTSEG-, and 30-
amino acid sequence, TRSRSHTSEG-TRSRSHTSEG-TRSRSHTSEG, by a combined 
pH-metric and spectroscopic ( UV-VIS, CD, NMR ) study. 
The results of a study on the interaction of Ni(II) ions with the fragments of Cap43 
protein containing respectively two and three repeated –TRSRSHTSEG– amino acid 
sequences showed that each 10-amino acid fragment coordinates one metal ion. The 
coordination of the metal ion starts from the imidazole nitrogen atom of the histidine 
residue, and with increasing the pH, Ni(II) ions are able to deprotonate successive 
peptide nitrogen atoms, forming Ni(II)–N- bonds, until a NiH-3L and Ni2H-6L species 
for the 20- and NiH-3L, Ni2H-6L and Ni3H-9L complexes for the 30-amino acid 
fragments, are formed (above pH 8). The formation of stable five-membered chelate 
rings by consecutive nitrogens is the driving force of the coordination process. 
 
 
Fig. 7.3  Scheme of 4N coordination pattern 
 
 
 At physiological pH (7.4) and mM concentrations of nickel(II), dependently 
on the metal-to-ligand molar ratio, the 20-amino acid fragment forms the Ni2L 
complex (2:1 molar ratio), while the 30-amino acid fragment forms the NiL (1:1), 
Ni2L (2:1), and Ni3L (3:1) complexes, where each metal ion is coordinated by the 
imidazole nitrogen atom of the histidine residue of each 10-amino acid sequence. 
The Ni2L and Ni3L complexes of these peptides are more stable by about 0.7–1.5 
orders of magnitude in comparison to the stability constants evaluated for these 
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systems considering an independent coordination of each metal ion to a sing1e 
TRSRSHTSEG amino acid sequence [28]. The coordination of two or three metal 
ions with 4N {NIm, 3N-} on this fragment (Ni2H-6L, Ni3H-9L complexes respectively) 
is not cooperative. 
The pH-metric and spectroscopic (UV-VIS, CD) results are deeply discussed in the 




7.3 NMR Study of Nickel Binding to C-terminal Sequence of Cap43 Protein 
 
7.3.1 NMR Spectroscopy 
 
NMR experiments were performed on a Bruker Avance 600 or 700 MHz 
spectrometer equipped with 5 mm TXI 1H-13 probe. Samples used for NMR 
experiments were 5 mM in concentration and dissolved in 90% H2O/10% D2O 
solutions. The acquisitions were performed at the temperature of 298 K.  A series of 
1D spectra of the free peptide was recorded at various pH values between 2.7 and 
10.0 by step of 1.0. The titration experiments of Ni(II)-containing samples with 
metal-to-ligand molar ratios of 1:1 and 2:1 were performed at pH 9.0 and for samples 
with 3:1 molar ratio were performed at pH 10.0. The pH of the sample was adjusted 
to reach the final pH by addition of 1 N NaOH or 1 N HCl. Nuclear Overhauser 
Enhancement Spectroscopy (NOESY) with mixing times of 500 ms, Rotating Frame 
Overhauser Enhancement Spectroscopy (ROESY) with mixing times of 250 ms and 
Total Correlation Spectroscopy (TOCSY) with a mixing time of 50 ms were also 
performed. The combination of TOCSY, NOESY and ROESY experiments was used 
to assign the spectra of both free and Ni(II)-bound peptides at various pH. Solvent 
suppression for 1D, TOCSY, NOESY and ROESY experiments was achieved using 
WATERGATE pulse sequence or using excitation sculpting with gradients. All 
NMR data were processed using XWINNMR (Bruker Instruments) software on a 











7.3.2  NMR Characterization of  C-terminal Sequence of Cap43 
 
For the 30aa Cap43 free peptide 1D, 2D 1H homonuclear TOCSY and NOESY 
spectra were performed at various pH.  Table 7.1 presents the chemical shifts 
assignments at pH 2.7.  
 
 Chemical Shift (ppm) 
Residue HN HA QA HB HB1 HB2 QB QG HD1 HD2 QD HE HE1 HE2 
T1 8.047 4.246  4.155    1.131       
R2 8.396 4.316   1.816 1.700  1.579   3.130 7.097   
S3 8.255 4.355     3.792        
R4 8.393 4.316   1.817 1.697  1.578   3.130 7.097   
S5 8.215 4.342     3.760        
H6 8.566 4.738   3.249 3.134   7.382 7.237   8.532 6.991 
T7 8.160 4.319  4.156    1.117       
S8 8.389 4.425     3.813        
E9 8.375 4.338   2.084 1.927  2.408       
G10 8.380  3.934            
T11 8.048 4.247  4.147    1.130       
R12 8.361 4.314   1.816 1.699  1.579   3.130 7.097   
S13 8.252 4.357     3.794        
R14 8.361 4.313   1.816 1.696  1.579   3.130 7.097   
S15 8.215 4.342     3.760        
H16 8.566 4.738   3.251 3.135   7.382 7.237   8.532 6.991 
T17 8.155 4.320  4.157    1.118       
S18 8.373 4.423     3.815        
E19 8.373 4.336   2.083 1.927  2.409       
G20 8.378  3.934            
T21 8.049 4.248  4.143    1.130       
R22 8.359 4.314   1.815 1.699  1.579   3.130 7.097   
S23 8.254 4.355     3.793        
R24 8.363 4.314   1.817 1.679  1.579   3.130 7.097   
S25 8.215 4.339     3.760        
H26 8.566 4.738   3.250 3.134   7.382 7.237   8.532 6.991 
T27 8.150 4.185  4.113    1.144       
S28 8.373 4.425     3.814        
E29 8.404 4.336   2.083 1.927  2.408       
G30 8.378  3.938            
 
Table 7.1   1H NMR chemical shifts for Ac-TRSRSHTSEG-TRSRSHTSEG-TRSRSHTSEG-Am  
   at pH 2.7. Degenerated protons are referred as Q. 
 
 
2D NOESY spectra at various pH showed only short range (i, i+1)  NOEs 
signals, as an indication of random coil secondary structure in agreement with the 
bioinformatic tools that were used to predict the structural conformation of the 
peptide using amino acid sequence information.  
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At pH 9.0 the resonances belonging to the 30 residues of the free peptide were 
assigned on the basis of 1D NMR spectra and 2D 1H homonuclear TOCSY and 
NOESY experiments. In the region between 6.6 and 8.5 ppm, only the aromatic 
resonances of three histidine residues (HE1 and HD2, 7.607 ppm and 6.888 ppm 
respectively) were present, the three of them overlapping at the same chemical shift. 
All the amide resonances were in a fast exchange with water at this pH and their 
resonances were lost. In the aliphatic region, the HA of histidines appeared at 4.600 
ppm under the water signal. Its assignment was based on the analysis of the TOCSY 
spectrum, where a correlation between histidinic HA and QB was clearly visible (QB 
3.029 ppm ). The TOCSY and NOESY spectra also allowed the assignment of the 
entire spin system of each amino acid. Table 7.2 presents the assignments at pH 9.0. 
 
 
 Chemical Shift (ppm)
Residue HA QA HB HB1 HB2 QB QG HD2 QD HE1 
T1 4.228  4.156    1.121    
R2 4.307   1.794 1.687  1.557  3.111  
S3 4.357     3.758     
R4 4.307   1.795 1.687  1.557  3.111  
S5 4.361     3.755     
H6 4.600     3.026  7.603  6.887 
T7 4.289  4.155    1.060    
S8 4.395     3.810     
E9 4.218   2.004 1.886  2.198    
G10  3.926         
T11 4.228  4.156    1.121    
R12 4.307   1.797 1.687  1.557  3.111  
S13 4.352     3.747     
R14 4.310   1.795 1.687  1.557  3.110  
S15 4.359     3.753     
H16 4.600     3.030  7.601  6.889 
T17 4.289  4.155    1.057    
S18 4.396     3.812     
E19 4.218   2.006 1.886  2.197    
G20  3.926         
T21 4.228  4.156    1.121    
R22 4.307   1.795 1.687  1.557  3.111  
S23 4.349     3.750     
R24 4.310   1.795 1.687  1.557  3.110  
S25 4.359     3.758     
H26 4.600     3.033  7.601  6.884 
T27 4.176  4.088    1.127    
S28 4.386     3.807     
E29 4.218   2.004 1.886  2.197    

















Table 7.2   1H NMR chemical shifts for Ac-TRSRSHTSEG-TRSRSHTSEG-TRSRSHTSEG-Am      
at pH 9.0. Degenerated protons are referred as Q.
 102
7.3.3 NMR Characterization of  Ni(II)  Binding to C-terminal Sequence of Cap43 
 
For the peptide-Ni(II) species, in order to test the coordination properties of 
individual mono-histidinic motif, the analysis was performed at different Ni(II)-to-
ligand molar ratios (1:1, 2:1 and 3:1, respectively). The pH was chosen to approach 
maximum formation of the major planar diamagnetic species, as evidenced by 
potentiometric and spectroscopic measurements (pH=9 for 1:1 and 2:1 and pH=10 
for 3:1) [30] (v. chapter 8).  
The binding mode of Ni(II) to the three TRSRSHTSEG mono-histidinic motifs of 
Cap43 peptide, monitored by studing a series of 1D 1H,  2D TOCSY and ROESY 
spectra at the different molar ratios (1:1, 1:2 and 1:3) for the peptide-metal system, is 
the same for the three molar ratios. 
Addition of increasing amounts of Ni(II), at pH 9, causes the incremental loss in 
intensity of a number of resonances, commensurate with this is the appearance of a 
new set of peaks. These new resonances increase in intensity with increasing 
additions of Ni(II).  
From the initial molar ratio 1:1 to the final 1:3, the two sets of the aromatic protons 
on the three histidines H6, H16 and H26  showed exactly the same upfield shift with a 











Fig. 7.4 Changes in intensity and chemical shift of the histidine aromatic protons 
(HE1 and HD2) by increasing nickel concentration. Comparison of the aromatic 
region of 1D 1H NMR spectra of 30aa Cap43 peptide-Ni(II) in the molar ratios of 
1:0, 1:1. 1:2, 1:3, respectively. 
Nd1 
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The new peaks increase in intensities with increasing of nickel concentration 
(fig. 7.4), suggesting the progressive involvement of the aromatic protons HE1 and 
HD2 for all three distinct histidine residues of the Ac-TRSRSH6TSEG-
TRSRSH16TSEG-TRSRSH26TSEG-Am peptide. The strong shift experienced by the 
HE1 protons respect to HD2 is due to their higher proximity to the metal ion.  
HD2 is in the opposite side of the ring respect to the imidazolic nitrogen Nd1 
involved in the complexation (fig. 7.4 b).  
Strong shifts affect also the histidine HA and HB protons (HA 3.451 ppm, ∆δ =        
-1.149; QB 2.883 ppm, ∆δ= -0.146). In the free peptide, the aliphatic protons of 
arginine R2, R4, R12, R14, R22 and R24, experience equivalent chemical environments 
resulting in overlap in their resonances. On the contrary, the addition of Ni(II) causes 
a strong differentiation on their signals. In particular we can assign HA 4,024 ppm, 
HB1 2,209 ppm, HB2 2,047 ppm, QG 1,918 ppm, QD 3,290 ppm for R4, R14, R24  and  
HA 4,147 ppm, HB11,719 ppm, HB2 1,619 ppm, QG 1,524 ppm, QD 3,097 ppm for 














Fig. 7.5 Superimposition of 2D 1H TOCSY spectra of free 30aa peptide (red) and  
  30aa peptide-Ni(II) complex (green) at 1:3 molar ratio. 
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This differentiation is due to the fact that the R4, R14 and R24 residues are directly 
involved in the complex environment by the nitrogen amide HN, and the metal-
binding causes stronger shifts in their proton resonances than for the R2, R12, R22  
residues, which are not directly involved in the coordination and remain, therefore, 
less perturbed. Consequently, the two different chemical environments for the 
arginine residues result in two new distinct spin systems that appear in the TOCSY 
and ROESY spectra. 
In the same way, due to their direct involvement in the metal interaction, the proton 
resonances of serine residues S5, S15, S25 respect to S3, S8, S13, S18, S23 and S28, 
appear at upfield chemical shift. 
Threonine residues are located in position 1 and 7 in each repeated 10-amino acid 
fragment. From 1D and 2D spectra, small perturbations in the proton resonances 
after addition of nickel are clearly visible. Threonines in position 7, are closer to the 
coordination centre, respect to those in position 1. For this reason they are more 
sensitive to the chemical environment changes due to the metal. This fact permits to 
fix the correct assignments. Notably, spin systems that are unaffected by Ni(II) 













Fig. 7.6 Comparison of aliphatic region of 1D 1H NMR spectra of 30aa Cap43 
peptide -Ni(II) in the molar ratios  1:0, 1:1, 1:2, 1:3. 
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residue free peptide 
peptide-Ni(II) 
 complex 1-3 
chemical shift
 diff 
R2 HA 4.313 4.147 -0.166 
R2 HB1 1.803 1.719 -0.084 
R2 HB2 1.694 1.619 -0.075 
R2 QG 1.561 1.524 -0.037 
R2 QD 3.111 3.097 -0.014 
R4 HA 4.313 4.024 -0.289 
R4 HB1 1.803 2.209 0.406 
R4 HB2 1.694 2.047 0.353 
R4 QG 1.561 1.918 0.357 
R4 QD 3.111 3.290 0.179 
S5 HA 4.380 4.066 -0.314 
S5 QB 3.793 3.628 -0.165 
H6 HA 4.600 3.451 -1.149 
H6 QB 3.029 2.883 -0.146 
H6 HD2 6.888 6.873 -0.015 
H6 HE1 7.607 7.435 -0.172 
T7 HB 4.292 4.168 -0.124 
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Fig. 7.7  Chemical shifts assignment, before and after nickel interaction, for the residues
in the mono-histidine fragment -T1R2S3R4S5H6T7S8E9G10–  involved in the complex
formation. The chemical shift differences are also reported in the plot. The behavior
appears to be the same for each of the three repeated region Ac-TRSRSHTSEG-






It was not possible to obtain sequential main chain HN ROE connectivities at 
pH 9, which is the pH required for Ni(II) binding, due to rapid exchange of the labile 
protons with the bulk water. In the absence of comprehensive ROESY data, large 
chemical shift changes upon Ni(II) coordination (∆δ>0.3 ppm) can indicate the 
residues directly involved in coordination. 
From NMR experiments, the shifts induced by Ni(II) were consistent with the 
binding of the metal ion in a square-planar site formed by four nitrogen atoms from 
H6+i (Nd1,NH) and from NH of S5+i and R4+i (where i = 0, 10, 20), of each 10-
aminoacid fragment. Strong shifts in the aliphatic proton resonances of arginine 
suggest an involvement of  the side-chain in the complex formation and/or a 
conformational rearrangement. 
 In conclusion, NMR studies performed on the 30-amino acid peptide, support 
the existence of relatively effective metal binding site in the C-terminal region of 
Cap43 protein.  














Fig. 7.8 Scheme of 4N coordination pattern of TRSRSHTSEG Cap43 fragment-
Ni(II) complex. The circles indicate the most affected protons after nickel 
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Abstract
Cap43 protein has been tested for metal binding domains. The protein, speciﬁcally induced by nickel compounds in cultured
human cells, had a new mono-histidinic motif consisting of 10 amino acids repeated three times in the C-terminus.
The 20-Ac-TRSRSHTSEG–TRSRSHTSEG (Thr341–Arg–Ser–Arg–Ser–His346–Thr–Ser–Glu–Gly–Thr–Arg–Ser–Arg–Ser–
His356–Thr–Ser–Glu–Gly360 – peptide 1) and the 30–Ac-TRSRSHTSEG–TRSRSHTSEG–TRSRSHTSEG (Thr341–Arg–Ser–Arg–
Ser–His346–Thr–Ser–Glu–Gly–Thr–Arg–Ser–Arg–Ser–His356–Thr–Ser–Glu–Gly–Thr–Arg–Ser–Arg–Ser–His366–Thr–Ser–Glu–
Gly370 – peptide 2) amino acids sequence has been analyzed as a site for Ni(II) binding.
A combined pH-metric and spectroscopic (UV–visible, CD, NMR) studies of Ni(II) binding to both fragments were performed.
The 20-amino acid peptide can bind one and two metal ions while the 30-amino acid fragment one, two and three metal ions. At
physiological pH, depending on the metal to ligand molar ratio, peptide 1 forms the Ni2L species while peptide 2 the NiL, Ni2L and
Ni3L complexes where each metal ion is coordinated to the imidazole nitrogen atom of the histidine residue of the 10-amino acid
fragment. Octahedral complexes at pH 8–9 and planar 4N complexes with (NIm, 3N
) bonding mode at pH above 9, are formed.
This work supports the existence of an interesting binding site at the COOH-terminal domain of the Cap43 protein.
 2004 Elsevier Inc. All rights reserved.
Keywords: Stability constants; Spectroscopic study; Nickel(II) complexes; Cap43 fragments
1. Introduction
Nickel is an essential element for many archea, bac-
teria and plants and may yet be found to play a role in
the metabolism of higher organisms [1–3]. Although a
deﬁciency disease for nickel in humans has not been
identiﬁed, there is substantial evidence for the essential
status of nickel [4]. However, under some circumstances
nickel compounds are potent human carcinogens as re-
ported from International Agency for Research on
Cancer [5]. Humans are exposed to carcinogenic nickel
compounds both occupationally and environmentally.
Animals studies indicate that substantial variation in the
carcinogenic potential of nickel compounds occurs,
causing multiple types of cellular/nuclear damage. The
majority of cellular damage may ultimately result in
altered gene expression, rather than in direct DNA
damage [6–9]. Ni(II) crosses cell membranes via calcium
channel and probably competes with Ca2þ for speciﬁc
intracellular receptors [10–12]. Ni(II) has been shown to
block Ca2þ channels and release stores of free intracel-
lular Ca2þ in a variety of systems, and some studies have
reported that longer exposure to nickel compounds can
elevate intracellular Ca2þ.
Cap43 is a novel gene induced by a rise in free in-
tracellular Ca2þ following nickel exposure [13,14]. No
other metal compounds signiﬁcantly induced expression
of this gene, indicating that it was expressed with
marked speciﬁcity to Ni(II) exposure [15].
Cap43 expressed a 3.0-kb mRNA encoding a Mr
43,000 protein. The protein was not found in the nu-
cleus, but was localized in the perinuclear region and
cytoplasm. Although Ni(II) is known to induce heat
shock proteins (HSPs), metallothioneins (MTs) and
acute phase reactant proteins (APRs), none of these
*Corresponding author. Tel.: +39-079229529; fax: +39-079271305.
E-mail address: zoroddu@uniss.it (M.A. Zoroddu).
0162-0134/$ - see front matter  2004 Elsevier Inc. All rights reserved.
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genes were speciﬁc to nickel and other heavy metals such
as cadmium, mercury, lead and zinc also induced these
genes. It has been suggested that the function of these
three families of genes is in the detoxiﬁcation and pro-
tection against oxidative stress induced by metals. Most
of them have been proven to contain metal-binding
domains. For example, MTs have high aﬃnity for
metals due to their high cysteine content [16]; puriﬁed
Limulus C-reactive protein, a member of the APR
family, has sulphydryl groups that bind strongly to
mercury [17] and HSPA from Helicobacter pylori, fea-
tures a series of cysteine and histidine residues, resem-
bling anchoring binding site for metal ions [18].
Although, Cap43 has no cysteine or histidine-rich motifs
for metal binding, it has a mono-histidine fragment, 10
amino acids (Thr–Arg–Ser–Arg–Ser–His–Thr–Ser–Glu–
Gly) repeated three times, resembling a nickel binding
motif at the COOH terminus (Fig. 1). It should be
mentioned that such mono-histidine fragments, e.g. oc-
tapeptide repeated regions in prion proteins, play a
critical role in metal metabolism using set of His imi-
dazoles as the binding sites for metal ions [19]. The
ﬁnding of the Cap43 protein makes it an interesting
candidate for studies of molecular mechanisms of nickel
carcinogesis.
The present paper reports the results of com-
bined spectroscopic and potentiometric studies on the
nickel(II) complexes of the 20-(TRSRSHTSEG–
TRSRSHTSEG, peptide 1) and 30-(TRSRSHTSEG–
TRSRSHTSEG–TRSRSHTSEG, peptide 2) amino acid
sequences of C-terminal part of the Cap43 protein. The
imidazole nitrogen atom of histidine residue is essential
bonding site for nickel(II) ion, and the 20- and 30 amino
acid sequences contain two and three histidine residues,
respectively. Therefore, this study was also performed in
order to examine the bonding abilities of these frag-
ments to more than one metal ion.
2. Experimental
2.1. Peptide synthesis and puriﬁcation
a-cyano-4-hydroxycinnamic acid was purchased from
Sigma (Sigma Chemical Co., St. Louis, MO, USA).
High performance liquid chromatography (HPLC)-
grade triﬂuoroacetic acid (TFA) was purchased from
Fluka (Buchs, Switzerland), HPLC-grade H2O from
Romil Ltd. (Amman Technik SA, K€olliken, Switzer-
land) and acetonitrile was purchased from Biosolve Ltd.
(Chemie Brunschwig, Basel). All other chemicals were of
highest purity and were used without further puriﬁca-
tion. All amino acid derivatives were obtained from
Novabiochem (L€aufelﬁngen, Switzerland) and other
reagents from Fluka and Sigma Chemie (Buchs,
Switzerland).
The peptides were chemically synthesized using so-
lid phase Fmoc chemistry in an Applied Biosystems
Fig. 1. Ten amino acids (Thr–Arg–Ser–Arg–Ser–His–Thr–Ser–Glu–Gly) sequence.
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Synthesizer [20]. The synthesis was performed using a
ﬁvefold excess of Fmoc amino acid derivatives, DCCI
and HOBt as activating agents and a 60 min coupling
time. Side chain protecting groups included: triphe-
nylmethyl group for His; pentamethyl-chroman-sulfo-
nyl group for Arg; t-butyl group for Glu, Ser and
Thr. The peptides were deprotected and cleaved from
the resin by treatment with 2.5% H2O, 5% triethylsi-
lan in TFA for 2 h at room temperature. After re-
moval of the resin by ﬁltration, the peptides were
precipitated with tert-butyl-methyl-ether, centrifuged
and the pellets resuspended in 50% acetic acid and
lyophilized.
Crude peptides were reconstituted in 1 ml 50% acetic
acid in H2O and low molecular weight contaminants
were removed by gel ﬁltration on Sephadex G-25. The
materials eluted in the void volume were lyophilised,
reconstituted in 1 ml 50% acetic acid in H2O and
subjected to RP-HPLC on a Vydac column (250 22
mm, 10–15 lm). The column was eluted at a ﬂow rate
of 9 ml/min by a linear gradient of 0.1%TFA/acetoni-
trile on 0.1%TFA/H2O, rising within 60 min from 10%
to 100%. The optical density of the eluate was moni-
tored at 220 or 280 nm. Fractions were collected and
analysed by MALDI-TOF MS. Fractions containing
the peptide of the expected molecular weight were
pooled and lyophilised.
2.2. Potentiometric measurements
Stability constants for protons and Ni(II) complexes
were calculated from pH-metric titrations carried out
in argon atmosphere at 298 K using a total volume of
2 cm3. Alkali (NaOH, 0.1 M) was added from a 0.250
cm3 micrometer syringe which was calibrated by both
weight titration and the titration of standard materials.
The concentration of peptide 1 was 2 103 M and the
ligand to metal molar ratio was 1.1:1 and 1.1:2. For
peptide 2, the concentration was 1.3 103 M and the
ligand to metal molar ratio was 1.3:1, 1.3:2 and 1.3:3.
The pH-metric titrations were performed in ionic
strength 0.10 M (KNO3) on a MOLSPIN pH-metric
system using a Russel CMAW 711 semi-micro com-
bined electrode calibrated in hydrogen ion concentra-
tions using HNO3 [21]. The SUPERQUAD [22] and
HYPERQUAD [23] computer programs were used for
stability costant calculations. Standard deviations refer
to random errors only. They are, however, a good in-
dication of the importance of a particular species in the
equilibrium. The sample were titrated in the pH region
2.5–10.5. In whole pH range for the solutions con-
taining Ni(II) ions and the peptide 1 (2:1, metal to
ligand molar ratio) or peptide 2 (2:1 and 3:1, metal
to ligand molar ratio), the precipitations were not
observed.
2.3. Spectroscopic measurements
Solutions for CD and UV–visible measurements
were of similar concentrations to those used in the
potentiometric studies. Absorption spectra were re-
corded on a Beckman DU 650 spectrophotometer.
Circular dichroism (CD) spectra were recorded on a
Jasco J-715 spectropolarimeter in the 750–250 nm
range. The values of De (i.e., el  er) and e were cal-
culated at the maximum concentration of the partic-
ular species obtained from the potentiometric data.
NMR experiments were performed on a Varian 300-
VXR spectrometer. One-dimensional experiments were
carried out in D2O solution at a peptide concentration
of 1.5 102 M and peptide: Ni(II) ratio of 1.1:1.
Above pH 8 there was precipitation reaction under the
condition used for NMR experiment.
3. Results and discussion
3.1. Protonation constants
The potentiometrically measured protonation co-
stants for the ligands studied and for comparable pep-
tides [24,25] are shown in Table 1 along with the
calculated stepwise constants assigned to the respective
peptidic functions. The 20-amino acid sequence (peptide
1) can be considered as a H5L ligand; the deprotonation
involves two histidine residues (pKa ¼ 6:70 and 5.89)
[24,25] and two side chains of c-carboxylic group of the
Glu residues and a C-terminal COOH (pKa ¼ 4:71, 4.20,
3.56) [26].
The 30-amino acid sequence (peptide 2) is a H7L li-
gand where the deprotonation involves three histidine
residues (pKa ¼ 6:88, 6.26 and 5.71), three side chains of
c-carboxylic groups of the Glu residues and a C-termi-
nal COOH (pKa ¼ 4:76, 4.34, 3.91, 3.39). As we can see
from the values of the pKa reported in Table 1, the ﬁrst
imidazole nitrogens of the histidine residues for both
peptides investigated, peptides 1 and 2, are about 0.5
order of magnitude more acidic than the histidine in
the monohistidinic 14-amino acid sequence of Cap43
C-terminal [24].
3.2. Ni(II) complexes containing one metal ion
Potentiometry detects a range of Ni(II) complexes in
the pH range 2.5–10.5 with the formation costants re-
ported in Tables 2 and 3. The values of logK
(logK ¼ log bðNiHjLÞ  log bHnL), the protonation
corrected stability constants which are useful to com-
pare the ability of various ligands to bind a metal ion,
are reported in Table 2 for 1:1 complexes [27]. Spec-
troscopic properties of the major complexes identiﬁed
are given in Table 5.
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The histidine residues of both Cap43 C-terminal
fragments can be the primary sites for the interaction of
Ni(II) ions [24,25,28]. Ni(II) forms three monomeric
species with peptide 1 and ﬁve monomeric species with
peptide 2, respectively (Figs. 2 and 3). NiH1L species
(logK ¼ 11:41 and )10.89 for the peptides 1 and 2,
respectively, Table 2) starts to form at pH about 7. It
involves the coordination of imidazole nitrogen and a
deprotonated amide nitrogen atom of a histidine resi-
due. The stability of these complexes is comparable to
each other and is one order of magnitude higher than
that of the 22-amino acid (Sequence 1, Table 2). This
stabilization may result from a diﬀerent amino acid se-
quence and diﬀerent structural organization of the
peptides in Ni(II) complexes [29]. At pH 7.5 starts to
form NiH3L species (logK ¼ 27:95 and )27.14 for
peptides 1 and 2, respectively, Table 2). It comes from
the deprotonation of the other two amides from the
backbone to give a 4N chromophore (NIm, 3N
) as in
the scheme in Fig. 4. The absorption and CD spectra of
these complexes are typical for 4N planar complexes
(Table 5) [24,25,28]. Above pH 9 NiH4L species starts
to form (Figs. 2 and 3); it likely comes from the de-
protonation of a guanidine residue or the pyrrolic ni-
trogen atom of histidine residue (pKa ¼ 11:54 and 10.19
for peptides 1 and 2, respectively) [24,25].
NiHL and NiL species, were also found, from po-
tentiometric data calculations, for peptide 2. The NiHL
species, the maximum formation of which is obtained at
pH 6.0–6.5 (Fig. 3) is the 1N {NIm} complex with one
protonated imidazole nitrogen atom of the second his-
tidine residue. The deprotonation constant of the NiHL
(NiHL¡NiL+Hþ) is )6.87; this value ﬁts very well the
deprotonation constant of imidazole nitrogen atom of
histidine residue ()6.88, Tables 1 and 2). Therefore, it
may suggest that the NiHL and NiL species are the
Table 1
Protonation constants for Ac-TRSRSHTSEG–TRSRSHTSEG (peptide 1) and Ac-TRSRSHTSEG–TRSRSHTSEG–TRSRSHTSEG (peptide 2)
and comparable peptides at 298 K, I ¼ 0:10 M (KNO3)
Peptide log b/species
HL H2L H3L H4L H5L H6L H7L
Peptide 1 6.70 0.01 12.59 0.01 17.30 0.01 21.50 0.01 25.06 0.01
Peptide 2 6.88 0.01 13.14 0.01 18.85 0.01 23.61 0.01 27.61 0.01 31.86 0.01 35.25 0.01
Cap43 (14 a.a. sequence)a 6.35 0.01 10.36 0.01
Sequence 1 ;b 11.79 22.54 32.62 42.65 51.85 57.84
Stepwise protonation constants logK
NIm NIm NIm COO
 COO COO COO
Peptide1 6.70 5.89 4.71 4.20 3.56
Peptide 2 6.88 6.26 5.71 4.76 4.34 3.91 3.39
Cap43 (14 a.a. sequence)a 6.35 4.01
Sequence 1 ;b 5.99
aRef. [24].
bRef. [25].
* Sequence 1, Ac-SGRGKGGKGLGKGGAKRHRKVL-Am.
Fig. 2. Species distribution curves for Ni(II) – peptide 1, molar ratio
1:1.
Fig. 3. Species distribution curves for Ni(II) – peptide 2, molar ratio
1:1.
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complexes with the same 1N {NIm} bonding mode. The
absorption and CD spectra with changing the pH clearly
support the presence in solution of the octahedral com-
plexes till pH 8, for both peptides. In UV–visible spectra
one d–d band at 390 nm (with e 20–30 M1 cm1) is
observed (mM concentration of nickel(II)).
Variable pH NMR study in D2O at 300 MHz from
pH 3 to pH 8 was used to evaluate the pKa of the glu-
tammate carboxylic group from the upﬁeld of the c-CH2
Glu, and the pKa of the histidine residue from the shifts
of the proton resonances of H(2) and H(4) for peptides 1
and 2. The resonances belonging to the 20-amino acid
peptide were assigned on the basis of the 1D NMR
spectra. The following assignment at pH 3 have been
made: d 8.58 (CH-2 of His); 7.27 (CH-4 of His); 3.94 (a-
Glu); 3.82 (b-Ser); 3.2 (b-His); 3.15 (d-Arg); 2.46 (c-
Glu); 2.03 (Thr); 1.8 (b-Arg); 1.6 (c-Arg); 1.14 (c-Thr).
An overlap among the histidine a-proton appears as
usually downﬁeld of the other a-proton signals and it is
partly obscured by the HDO signal. The amide protons
appear to exchange rapidly with the solvent protons and
are not observed in the NMR spectra. Interestingly, the
multiplet centered at 1.14 ppm observed at pH 3 and
assigned to c-CH3–Thr, splits at pH 8 into two doublets
centered at 1.2 and 1.1, showing that the threonine
residues are not equivalent each other when the pH is
raised to 8. The following assignments at pH 8 have
been made: d 7.77 (CH-2 of His); 6.9 (CH-4 of His) for
peptide 1. Comparison of the 1D NMR spectra of
TRSRSHTSEG–TRSRSHTSEG and Ni(II) species
were performed a pH 7.2. Proton NMR spectra show
signiﬁcant chemical shifts changes, as a result of com-
plexation, although the broadening of the lines made the
interpretation of NMR spectra diﬃcult. Nevertheless,
some information on the binding mode of Ni(II) can be
obtained. A minor shift of the two histidine aromatic
protons d at 8.43 (CH-2 of His) and d at 7.23 and 7.199
(CH-4 of His) together with a visible changes involving
the a-proton region of the spectrum were observed.
Unfortunately, above pH 8 was not possible to have
information from NMR spectra because there was pre-
cipitation reaction in the conditions used.
3.3. Ni(II) complexes containing more than one metal ion
The coordination study has been carried out also for















































































































































































































































































































































































































































































































































Fig. 4. Scheme 4N.
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and 3:1 (for peptide 2) in order to study the possible
involvement of the set of histidines (His6, His16 and
His26) in the coordination to the metal ion.
Five metal complex species can be ﬁtted to the ex-
perimental titration curves obtained for Ni(II) – peptide
1 or peptide 2 systems with 2:1 metal to ligand molar
ratio (Table 3). In Figs. 5 and 6 are reported the speci-
ation curves for these complexes in the solution. The
ﬁrst species obtained for the peptides 1 and 2, the Ni2L,
starts to form at pH 5–5.5 and it reaches the maximum
formation at pH 7–7.5. The stoichiometry of this com-
plex suggests the 2 1N {NIm}{NIm} coordination
mode (Table 4). The logK value for the Ni2L complex
is about 0.7 and 1.3 orders of magnitude higher (for
peptides 1 and 2, respectively) in comparison to that
()7.24) obtained for the 14-amino acid sequence with
the same bonding mode (Table 4, one metal ion coor-
dinated to one histidine residue, )3.62). By raising the
pH, consecutive deprotonations take place to give
the Ni2H1L and Ni2H2L complexes. Above pH 8 the
Ni2H4L species with maximum formation at pH 8.7,
and the Ni2H6L with maximum formation above pH 9
can also be ﬁtted to the experimental titration curves.
The stoichiometry of the Ni2H6L complex is in agree-
ment with the 4N {NIm, 3N
} coordination of two
metal ions to the peptides. This bonding mode of each
metal ion is supported by spectroscopic data. The pa-
rameters of the absorption and CD spectra clearly in-
dicate the formation of 4N planar diamagnetic complex
with the {NIm, 3N
} coordination mode (Table 5). The
logK value of Ni2H6L complex, for peptide 1, is 0.6
order of magnitude lower compared to that evaluated
when each metal ion is coordinated independently to the
14-amino acid fragment with the same coordination
mode (Table 4, )56.32). It means that the coordination
of two metal ions to the two repeated 10-amino acid
sequence with 4N {NIm, 3N
} bonding mode is not of
cooperative type. The Ni2H6L complex of the peptide 2
is stabilized by about 0.7 order of magnitude compared
to that obtained for the independently coordination of
each metal ion to the 14-amino acid sequence ()56.32,
Table 4).
Six metal complex species could be ﬁtted to the ex-
perimental titration curves obtained for the Ni(II) –
peptide 2 system with metal to ligand molar ratio 3:1,
Ni3L, Ni3H1L, Ni3H3L, Ni3H6L, Ni3H8L and
Ni3H9L (Table 3, Fig. 7). The coordination of metal
ion starts at pH around 5 and Ni3L complex (maximum
concentration at pH 6.6), is formed (Fig. 7). The ab-
sorpion and CD spectra indicate the formation in so-
Table 3
Stability constants for Ni(II) complexes containing two or three metal ions with Ac-TRSRSHTSEG–TRSRSHTSEG-Am (peptide 1) and Ac-
TRSRSHTSEG–TRSRSHTSEG–TRSRSHTSEG-Am (peptide 2) at 298 K, I ¼ 0:10 M (KNO3)
Peptide log b/species
Ni2L Ni2H1L Ni2H2L Ni2H4L Ni2H6L Ni2H7L
Peptide 1 6.11 0.03 )1.95 0.07 )10.27 0.08 )26.70 0.03 )44.31 0.02
Peptide 2 6.03 0.07 )9.93 0.07 )26.79 0.09 )43.68 0.03 )54.19 0.05
Ni3L Ni3H1L Ni3H3L Ni3H6L Ni3H8L Ni3H9L
Peptide 2 9.51 0.05 2.30 0.03 )14.14 0.04 )39.28 0.04 )57.03 0.04 )66.42 0.04
Fig. 5. Species distribution curves for Ni(II) – peptide 1, molar ratio
2:1.
Fig. 6. Species distribution curves for Ni(II) – peptide 2, molar ratio
2:1.
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lution of octahedral complexes at pH 8.5 (data not
shown). The stoichiometry of Ni3L complex suggests
3 1N {NIm}{NIm}{NIm} coordination mode where
each metal ion is coordinated to the imidazole nitrogen
atom of the histidine residue of each 10-amino acid
fragment of the peptide 2 (Table 4). The logK value for
this complex is about 1.5 order of magnitude higher that
that calculated for the same coordination mode of three
systems containing one metal ion coordinated to the 14-
amino acid sequence (3)3.62, Table 4 ). It means that
peptide 3 coordinated to three metal ions at His6, His16
and His26 residues (one metal ion at one histidine resi-
due) is additionally stabilized. With increasing the pH,
sequential deprotonation and coordination to peptide
nitrogen atoms occur and Ni3H1L, Ni3H3L,
Ni3H6L, Ni3H8L and Ni3H9L complexes are
formed. The spectroscopic data are consistent with the
results obtained from the potentiometric data calcula-
tions. In the solution at pH above 8.5, the formation of
planar diamagnetic complexes is observed (Table 5). For
Ni3H9L complex, each metal ion is coordinated to the
10-amino acid fragment with 4N {NIm, 3N
} bonding
mode. The logK value for this complex ()85.27) is
about 0.8 order of magnitude lower compared to that
evaluated for the system where each metal ion is coor-
dinated to the 14-amino acid sequence in an indepen-
dently way (3)28.16, Table 4). The coordination of
three metal ions to the three repeated 10-amino acid
Table 4
LogK values for the Ni(II) complexes with peptide 1 (20-amino acids) and peptide 2 (30-amino acids) containing more than one metal ion




logK for the complexes containing two coordinated metal ions
2 1N 1N+2N 2 2N 2 3N 2 4N
{NIm}{NIm} {NIm}{NIm,N
} 2 {NIm,N} 2 {NIm,2N} 2 {NIm,3N}
Peptide 1 )6.48 ()7.24) )14.54 )22.86 )39.29 ()39.64) )56.90 ()56.32)
Peptide 2 )5.94 )21.90 )38.76 )55.65
logK for the complexes containing three coordinated metal ions










Peptide 2 )9.34 ()10.86) )16.55 ()18.16) )32.99 )58.13 ()59.46) )75.88 ()76.14) )85.27 ()84.48)
Log K values for the Cap43 (14-amino acids peptide) are reported for comparison.
a logK ¼ logbðNiHjLÞ  logbðHnLÞ.
bRef. [24].
Table 5
Spectroscopic data for Ni(II) complexes of Ac-TRSRSHTSEG–TRSRSHTSEG (peptide 1) and Ac-TRSRSHTSEG–TRSRSHTSEG–
TRSRSHTSEG (peptide 2)
Peptide, species coordination mode Absorption CD
k (nm) ea k (nm) Dea
Peptide 1
NiH3L (NIm, 3N) 437b 168 512b +1.392
pH 9 420b )3.091
283c +1.968
Ni2H6L 2 (NIm, 3N) 439b 147 513b +1.304
pH 10 420b )2.969
Peptide 2
NiH3L (NIm, 3N) 437b 255 514b +2.339
pH 9 421b )5.344
283c +3.348
Ni2H6L 2 (NIm, 3N) 437b 240 512b +2.068
pH 9 420b )4.452
287c +2.098
Ni3H9L 3 (NIm, 3N) 438b 203 515b +1.547
pH 10 421b )3.696
a For e and De results, M1 cm1.
b d–d transition.
c Charge transfer transition N(amide)!Ni(II).
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fragments of the peptide 2 in the Ni3H9L complex
(3 {NIm, 3N} coordination mode) is also not coop-
erative (See Fig. 8).
4. Conclusions
The present paper reports the results of a study on the
interaction of Ni(II) ions with the fragments of Cap43
protein containing two and three repeated –
TRSRSHTSEG– amino acid sequence. The 10-amino
acid fragment may coordinate one metal ion. The co-
ordination of the metal ion starts from the imidazole
nitrogen atom of the histidine residue, and with in-
creasing the pH, Ni(II) ions are able to deprotonate
successive peptide nitrogen atoms, forming Ni(II)–N
bonds, until a NiH3L and Ni2H6L species for 20- and
NiH3L, Ni2H6L and Ni3H9L complexes for 30-
amino acid fragments, are formed (above pH 8). The
formation of stable ﬁve membered chelate rings by
consecutive nitrogens is the driving force of the coor-
dination process. At physiological pH (7.4) and mM
concentrations of nickel(II), dependently from metal to
ligand molar ratio, two repeated 10-amino acid frag-
ment forms the Ni2L complex (2:1 molar ratio), while
30-amino acid fragment forms the NiL (1:1), Ni2L (2:1),
and Ni3L (3:1) complexes where each metal ion is co-
ordinate by the imidazole nitrogen atom of the histidine
residue of each 10-amino acid fragment. The Ni2L and
Ni3L complexes of these fragments are more stable by
about 0.7–1.5 order of magnitude in comparison to that
evaluated for the systems with an independently coor-
dination of each metal ion to the 14-amino acid se-
quence with the same coordination mode. The
coordination of two or three metal ions with 4N {NIm,
3N} coordination mode of each metal ion (Ni2H6L,
Ni3H9L complexes), is not cooperative. In conclusion,
this work supports the existence of relatively eﬀective
metal binding site in the C-terminal region of Cap43
protein. Our result suggest that the entire Cap43 protein
could be one interesting target for Ni(II) ions.
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NMR STUDY OF NICKEL BINDING TO N-TERMINAL SEQUENCE 























9.1 Nickel binding to Histone H4 
 
Both water soluble and insoluble nickel compounds are implicated in the 
etiology of human lung and nasal cancers, although animal studies reveal that the 
insoluble nickel compounds, such as Ni3S2 are more potent carcinogens than their 
water soluble counterparts [1,2]. 
Water insoluble nickel compounds have been shown to enter cells by phagocytosis 
and to be stored inside cytoplasmic vacuoles, whose pH lowers to acidic values, thus 
accelerating the dissolution of insoluble nickel particles in a region of the cell very 










Fig. 9.1 Model of nickel uptake into cells. Cartoon illustrates the phagocytosis and 





The carcinogenic potency of nickel compounds is consistently related to the 
ability of Ni(II) to access chromatin and cause multiple types of cellular nuclear 
damage via direct or indirect mechanisms. The mechanistic concepts proposed for 
nickel carcinogenesis include promutagenic DNA damage [3,4], epigenetic effects in 
chromatin [5-7], and impairment of DNA repair [8].  
The binding of Ni(II) ions within the cell nucleus is a crucial element of all these 
concepts. Obviously, detection and chemical and structural description of specific 
Ni(II) binding sites in the nuclear compartment would provide molecular basis for a 
better understanding of the effects that eventually lead to cancer development. 
The DNA polymer binds Ni(II) only weakly [9], leaving nuclear proteins as possible 
targets for Ni(II). Due to their abundance in chromatin, histones seem to be the most 
likely ligands. In fact, the core histone octamer (formed by two copies of histones 
H3, H4, H2A and H2B) together with the linker histone H1, package eukaryotic 








Fig. 9.2 Nucleosome core particle: ribbon traces for the 146-bp DNA phosphodiester 
backbones (brown and turquoise) and eight histone protein main chains (pink for H3, 
H2A, H2B and blue for H4). The views are down the DNA superhelix axis for a) and 




General chemical preferences of Ni(II) and, in particular, the binding modes 
of Ni(II) to proteins [10] and peptides [11,12] indicate that His imidazoles and Cys 
thiols are preferred by Ni(II) amongst the donor groups provided by the amino acid 
residues of proteins. The linker histone H1 does not contain any His or Cys residue, 
while H3 and H2A histones, for instance, contain two or more such residues capable 
of strong coordination to this metal. 
In order to identify putative Ni(II) binding motifs on histones, we analyzed the data 
reported in the literature for amino acid sequences [13,14] as well as the structural 
data [15,18] of these core proteins, getting a better insight into the formation and 
physicochemical properties of Ni(II) complexes with selected motifs. 
Once considered as static nonparticipating structural elements, histones are now 
clearly recognized as integral and dynamic components of the machinery responsible 
for the regulation of gene transcription. In particular, histone N-terminal tails are 
central to the processes that modulate nucleosome structure and function.  
The N-terminal regions of the histone proteins are extensively and reversibly post-
translationally modified by acetylation, phosphorylation, ubiquitination and 
methylation. Of these modifications, acetylation has generated more interest since 
gene expression was directly correlated with histone acetylation. The site of 
acetylation is the lysine residue of the positively charged amino-terminal tails where 
each acetyl group added to a histone reduces its net positive charge weakening and 
modulating the interactions between histones and the surface of the nucleosome. 
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The positive charge of the histone tail is neutralized by acetylation to the lysine 
residues increasing the access to transcription factors and making active chromatin 
more available for modifications and the gene expression [19]. 
It has been reported that nickel is a potent suppressor of histone H4 acetylation, in 
both yeast and mammalian cells [20].  
Interestingly, an anchoring binding site for nickel ion on this protein, histidine H18, is 
close to sites for post-translational modification involved in nickel toxicity. 
All these informations point to the H4 tail as a candidate for a Ni(II) binding site in 
the histone octamer. Because of its structural position, this terminal part could be 
accessible for metal binding.  
For this reason we analyzed, for Ni(II) binding, the sequence of the N-terminal tail of 






Fig. 9.3    Sequence of Histone protein H4. The N-terminal tail are red 
highlighted. Histidine H18 are showed in green colour. 
 
 
Previously we had reported, by potentiometric and spectroscopic (Uv-Vis, 
CD) studies, about the interaction of Ni(II) with minimal models of the H4 tail: the 
two peptides with 6 amino acids Ac-AKRHRK-Am and with 22 amino acids Ac-
SGRGKGGKGLGKGGAKRHRKVL-Am, respectively[21-23].  
From these studies it resulted that the histidine residue can be a basic binding site for 
Ni(II) ions in the histone core of the nucleosome. Therefore, the H4 tail peptide 
fragment can potentially be one of the biologically relevant sites for nickel 
genotoxicity. 
Here we present our recent results on the coordination ability of Ni(II) to the N-
terminal tail of histone H4, the 30-amino acid peptide Ac-
SGRGKGGKGLGKGGAKRH18RKVLRDNIQGIT-Am, achieved by the use of 
multidimensional NMR spectroscopy. 
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9.2  NMR Study of Nickel Binding to N-terminal Sequence of H4 Histone 
 
9.2.1 NMR Spectroscopy 
 
NMR experiments were performed on a Bruker Avance 600 or 700 MHz 
spectrometers equipped with 5 mm TXI 1H-13 probe. Samples used for NMR 
experiments were 5 mM in concentration and dissolved in 90% H2O/10% D2O 
solutions. All acquisitions were performed at the temperature of 298 K.  The pH of 
the sample was adjusted to the final pH by addition of 1 N NaOH or 1 N HCl. The 
titration experiments on Ni(II)-containing samples with peptide-to-metal molar ratio 
of 1:1 were performed at pH 8.7.  Nuclear Overhauser Enhancement Spectroscopy 
(NOESY) with mixing times of 500 ms and Total Correlation Spectroscopy 
(TOCSY) with a mixing time of 50 ms were also performed. The combination of 
TOCSY and NOESY experiments was used to assign the spectra of both free and 
Ni(II)-bound peptide. Solvent suppression for 1D, TOCSY and NOESY experiments 
was achieved using WATERGATE pulse sequence or using excitation sculpting with 
gradients. All NMR data were processed using XWINNMR (Bruker Instruments) 

























9.2.2  NMR Characterization of  N-terminal Sequence of Histone H4 
 
A comparison of the 1D, 2D 1H homonuclear TOCSY and NOESY NMR 
spectra of H4 30aa free peptide and of peptide-Ni(II) species was performed at pH= 
8.7. This pH was chosen to approach maximum formation of the major planar 
diamagnetic species, as evidenced by potentiometric and spectroscopic 
measurements [22]. 
The resonances belonging to the 30-residues free peptide Ac-
SGRGKGGKGLGKGGAKRH18RKVLRDNIQGIT-Am were assigned on the basis 
of 1D NMR spectra and 2D 1H homonuclear TOCSY and NOESY experiments. The 
alkaline pH required for nickel binding results in exchange of the amide protons with 
bulk water. Therefore their resonances were lost. Only the aromatic resonances of 
histidine (HE1 and HD2 at 7.595 and 6.862 ppm, respectively) were present in the 
















Fig. 9.4 a) 1H 1D aromatic region of  the free peptide N-terminal sequence of 
Histone H4 in  dependence of pH, b) 2D 1H Tocsy spectra of the peptide a pH 2.7 




The stepwise procedure applied to achieve detailed assignments by using 1H 2D 
TOCSY and NOESY spectra made at pH 2.7 and at the successive points (pH 4.0-
8.0) enabled unproblematic assignments at pH 8.7 where exchange with bulk water 
suppressed HN  amidic protons. Table 8.1 reports the chemical shift assignments at 
pH 8.7. 
 
  Chemical shift ppm
Residue HA HB HB1 HB2 HG HG1 HG2 HN QB QD QD1 QD2 QE QG QG2 
S1 4.340    3.804   
G2 3.872               
R3 4.257  1.683 1.793      3.116    1.541  
G4 3.898               
K5 4.270  1.687 1.793      1.580   2.905 1.355  
G6 3.898               
G7 3.898               
K8 4.277  1.687 1.793      1.580   2.901 1.355  
G9 3.898               
L10 4.264    1.541    1.570  0.832 0.837    
G11 3.898               
K12 4.251  1.687 1.793      1.580   2.900 1.355  
G13 3.898               
G14 3.898               
A15 4.215        1.291       
K16 4.218  1.687 1.793      1.580   2.896 1.355  
R17 4.260  1.683 1.793      3.119    1.541  
H18 4.513  3.042 2.970    8.522        
R19 4.257  1.683 1.793      3.116    1.541  
K20 4.193  1.687 1.793      1.580   2.894 1.355  
V21 4.007 1.953            0.838  
L22 4.306    1.531    1.572  0.827 0.838    
R23 4.260  1.683 1.793    8.128  3.117    1.557  
I26 4.076 1.817    1.356 1.104   0.802     0.823 
Q27 4.252  1.934 2.042          2.309  
G28 3.898               
I29 4.186 1.839    1.384 1.126   0.810     0.841 
















Table 9.1   H NMR chemical shifts for Ac-SGRGKGGKGLGKGGAKRH RKVLRDNIQGIT-Am    1 18




9.2.3 NMR Characterization of Ni(II) Binding to N-terminal Sequence of Histone H4 
 
The binding mode of Ni(II) to the H4 sequence was studied at pH = 8.7 with 
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Unfortunately, at this final molar ratio precipitation was observed; nevertheless, clear 
information on the binding mode of the metal can be obtained from a series of 1D 
1H,  2D TOCSY and NOESY complex spectra up to molar ratio of 1:0.8. 
Both the histidine aromatic protons show an upfield shift of their signals upon 
metal coordination: HE1 proton appears now at 7.472 ppm, with ∆δ= -0.123 ppm 
respect to the free peptide, and HD2 proton moves to 6.837 ppm, with a ∆δ= -0.025. 
The effect of incremental addition of Ni(II) on 1H NMR signals for H18 ring protons 
has also been monitored. Figure 9.3(a) shows the 1H mono-dimensional spectra 
collected for a Ni(II) titration of our peptide at pH 8.7. Figure 9.5(b) indicates the 
change in absolute peak height for resolved HE1 proton on H18 ring plotted versus 
equivalents of Ni(II) up to 1.0 eq (from 0.8 to 1.0 eq a linear prediction was used). 
The appearance of a new set of signals for H18 ring protons HE1 and HD2 is clearly 
visible in the mono-dimensional spectra. However, only the HE1 peak intensities 
have been plotted in Figure 9.5 (b) as the HD2 signals are overlapped with both apo-
form and Ni(II)-form signals. The latter signals have reached about 90% of their 
maximal intensity after addition of 1 eq of Ni(II), suggesting that H18 binds Ni(II) 
with a high affinity, in a ratio close to 1:1. 
 
 
Fig. 9.5 a) Changes in intensity and chemical shift of the histidine aromatic protons 
(HE1 and HD2) by increasing nickel concentration. Comparison of aromatic regions 
of 1D 1H NMR spectra of H4 30aa peptide-Ni(II) binding in the molar ratios of 1:0, 
1:0.4, 1:0.6 and 1:0.8 respectively, b) Intensity, as absolute peak height, of selected 
peak HE1 as a function of added Ni(II). 
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Ni(II) has the ability to adopt a range of coordination geometries. Octahedral 
and tetrahedral geometries form high-spin paramagnetic complexes while a square-
planar or a five-coordinated square-pyramidal geometry produces a low-spin 
diamagnetic complex. The line-width at half-height for the new Ni(II) bound signals 
is comparable to the apo signals, indicating that Ni(II) coordinates to H18 in a low 
spin diamagnetic complex. The estimated 10% of free high-spin octahedral 
paramagnetic Ni(II) aqua ion is responsible for the slight broadening found in all the 
signals of the spectra. 
Comparison of the free peptide and peptide-Ni(II) complex 1D, 2D TOCSY spectra 
at pH 8.7 points out several additional peaks appearing upon coordination. 
Strong shifts involve the HA and HB protons of H18 (HA 3.481 ppm, ∆δ= -1.032; 
HB1 2.840 ppm, ∆δ= -0.202, HB2 2.709  ppm, ∆δ= -0.261). 
Moreover, new spin systems appear for R and K residues, attributable to K16 and R17, 
in which the strongly shifted resonance of the HA protons of K16 (at  3.937 ppm, ∆δ= 















Fig. 9.6  Superimposition of TOCSY spectra of free 30aa peptide (red) and 30aa 
peptide-Ni(II) (blue) 1:0.8 molar ratio. The new spin systems for Lys16, Arg17 and 
His18 after nickel interaction are also indicated. 
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The chemical shift values in the new system identified for K16 , R17  and H18, 




assignment free peptide 
ppm 
peptide :Ni(II) 
complex 1 :3 
ppm 
chemical shift diff 
ppm 
K16 QG 1.355 1.499 0.144 
K16 HB2 1.793 2.183 0.39 
K16 HB1 1.687 1.969 0.282 
K16 HA 4.218 3.937 -0.281 
R17 QD 3.119 3.119 0.000 
R17 QG 1.541 1.429 -0.112 
R17 HB2 1.793 2.255 0.462 
R17 HB1 1.683 2.019 0.336 
R17 HA 4.26 3.565 -0.695 
H18 HB1 3.042 2.84 -0.202 
H18 HB2 2.97 2.709 -0.261 
H18 HA 4.513 3.481 -1.032 
H18 HE1 7.595 7.472 -0.123 



















































Fig. 9.7 Chemical shift assignment for the residues K16, R17 and H18 in Ac-
SGRGKGGKGLGKGGAKRH18RKVLRDNIQGIT-Am directly involved in the 
complex formation, before and after nickel interaction; the chemical shifts 
differences are also reported in the plot. 
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The 2D NOESY spectra, respect to the TOCSY ones, showed additional 
meaningful cross-peaks. Although the alkaline pH required for Ni(II) binding, due to 
rapid exchange of the labile HN protons with the bulk water, did not allow the 
observation of the potential HNx-HNy or HNx-Hi  correlations, the aromatic histidine 
protons HE1 and HD2 clearly show a new set of NOE cross-peaks appearing after 
nickel binding. 
Preliminary check of the data showed that some of the NOEs involve both HE1 and 
HD2 interactions with  aliphatic protons HA, HB, HG of Lys K16 residue. 
The figure 9.8 represent the aromatic region of 2D NOESY spectra showing  the new 
spin systems. 
Presently, these data are under analysis in order to collect a detailed set of overall 



















Fig. 9.8  Superimposition of aromatic region for TOCSY (red) and NOESY (green) 
spectra, of peptide-Ni(II) 1:0.8 molar ratio. Some of NOE cross-peaks appearing 
after nickel binding are already assigned and found to involved HE1 and HD2 




From NMR experiments, the chemical shifts induced by Ni(II) coordination to the 
peptide were consistent with the binding of the metal ion in a square-planar site by 
four nitrogen atoms from His18 (Nd1,NH) and from Arg17 and Lys16 (NH). 
The proton NMR spectra showed significant downfield and upfield changes 
particularly with regard to the HA protons of the backbone as a result of 
complexation of Ni(II) to the peptide. 
The HB1, HB2, HG protons of arginine Arg17 and the HB1, HB2 protons of lysine 
Lys16 exhibited a downfield shift, suggesting a change of hydrophobic packing of the 
side chains following nickel binding. The appearance of new sets of NOE indicates 
that when Ni(II) forms 4N-complexes with the peptide ligand, the peptide 
conformation is dramatically affected; this aspect is particularly important with 
donors able to bind metal ions through the backbone peptide nitrogens, since they 
will influence both the physical and biological properties of the peptide itself. 
More detailed informations of the binding mode of Ni(II) to the N-terminal sequence 
of histone H4 and the relate conclusions will be available after the complete analysis 
of the data and the consequent structure calculations.  
At the moment, the results from NMR studies together with our previous 
spectroscopic (UV-Vis, CD) and potentiometric studies [21-23], support the 
existence of relatively effective metal binding sites in the N-terminal region of H4 
protein.  
These results suggest that the entire H4 protein could be an interesting target 
for Ni(II) ions. 
Although the complexation with Ni(II) at a physiological pH, under our experimental 
conditions, is not very effective, the formation of a rigid square planar complex may 
result, somehow paradoxically, in a higher specificity of Ni(II) to produce a 
particular conformation of the peptide [24]. The presence of positively charged 
residues close to the metal binding site in the H4 tail can result in a site-selectivity 
association of the Ni(II) complexed tail with the negatively charged DNA backbone 
[25,26]. In addition, the hydrophobic environment in the entire protein is expected to 
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enhance metal binding capabilities, due to the multiple non-bonding interactions 
available, as reported in the literature [27,29]. 
In conclusion, the histidine H18 residue can be a primary binding site for 
Ni(II) ions, therefore the H4 tail can potentially be one of the biologically relevant 
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